CA2076647C - Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them - Google Patents
Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them Download PDFInfo
- Publication number
- CA2076647C CA2076647C CA002076647A CA2076647A CA2076647C CA 2076647 C CA2076647 C CA 2076647C CA 002076647 A CA002076647 A CA 002076647A CA 2076647 A CA2076647 A CA 2076647A CA 2076647 C CA2076647 C CA 2076647C
- Authority
- CA
- Canada
- Prior art keywords
- fructo
- oligosaccharides
- branched
- fructose
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 title claims abstract description 114
- 238000000034 method Methods 0.000 title claims description 30
- 239000000203 mixture Substances 0.000 claims abstract description 62
- 239000004615 ingredient Substances 0.000 claims abstract description 18
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims abstract description 16
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 13
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 7
- 239000000654 additive Substances 0.000 claims abstract description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 4
- 239000000194 fatty acid Substances 0.000 claims abstract description 4
- 229930195729 fatty acid Natural products 0.000 claims abstract description 4
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 4
- 150000002632 lipids Chemical class 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract 2
- 102000004169 proteins and genes Human genes 0.000 claims abstract 2
- 238000002360 preparation method Methods 0.000 claims description 34
- 239000005715 Fructose Substances 0.000 claims description 29
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 26
- 229930006000 Sucrose Natural products 0.000 claims description 26
- 239000004067 bulking agent Substances 0.000 claims description 26
- 229960004793 sucrose Drugs 0.000 claims description 26
- 229930091371 Fructose Natural products 0.000 claims description 25
- 239000005720 sucrose Substances 0.000 claims description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 21
- 239000008103 glucose Substances 0.000 claims description 21
- 230000008569 process Effects 0.000 claims description 20
- 238000006460 hydrolysis reaction Methods 0.000 claims description 19
- 230000007062 hydrolysis Effects 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 17
- 229920001542 oligosaccharide Polymers 0.000 claims description 17
- 239000003765 sweetening agent Substances 0.000 claims description 17
- 229920002670 Fructan Polymers 0.000 claims description 16
- 235000013305 food Nutrition 0.000 claims description 15
- 150000002482 oligosaccharides Chemical class 0.000 claims description 14
- 229920001202 Inulin Polymers 0.000 claims description 13
- 235000003599 food sweetener Nutrition 0.000 claims description 13
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 13
- 229940029339 inulin Drugs 0.000 claims description 13
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 claims description 11
- 108010011485 Aspartame Proteins 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 11
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 11
- 230000015572 biosynthetic process Effects 0.000 claims description 11
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 11
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 10
- 235000013325 dietary fiber Nutrition 0.000 claims description 10
- 229920002472 Starch Polymers 0.000 claims description 9
- 230000001847 bifidogenic effect Effects 0.000 claims description 9
- 238000006116 polymerization reaction Methods 0.000 claims description 9
- 239000008107 starch Substances 0.000 claims description 9
- 235000019698 starch Nutrition 0.000 claims description 9
- 239000000605 aspartame Substances 0.000 claims description 8
- 235000010357 aspartame Nutrition 0.000 claims description 8
- 229960003438 aspartame Drugs 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 8
- 230000002255 enzymatic effect Effects 0.000 claims description 7
- 230000001013 cariogenic effect Effects 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 150000005846 sugar alcohols Chemical class 0.000 claims description 6
- 238000003786 synthesis reaction Methods 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 108010042889 Inulosucrase Proteins 0.000 claims description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 4
- 229930014626 natural product Natural products 0.000 claims description 4
- 241000282414 Homo sapiens Species 0.000 claims description 3
- 230000000670 limiting effect Effects 0.000 claims description 3
- 230000001603 reducing effect Effects 0.000 claims description 3
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 claims description 2
- ODEHMIGXGLNAKK-OESPXIITSA-N 6-kestotriose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 ODEHMIGXGLNAKK-OESPXIITSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 108010016626 Dipeptides Proteins 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- 229920002488 Hemicellulose Polymers 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 229920001100 Polydextrose Polymers 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 235000013681 dietary sucrose Nutrition 0.000 claims description 2
- 230000001882 diuretic effect Effects 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 239000000832 lactitol Substances 0.000 claims description 2
- 235000010448 lactitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 2
- 229960003451 lactitol Drugs 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229960001855 mannitol Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000001259 polydextrose Substances 0.000 claims description 2
- 235000013856 polydextrose Nutrition 0.000 claims description 2
- 229940035035 polydextrose Drugs 0.000 claims description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019204 saccharin Nutrition 0.000 claims description 2
- 229940081974 saccharin Drugs 0.000 claims description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 241000368571 Opsanus beta Species 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims 1
- 208000004880 Polyuria Diseases 0.000 claims 1
- 244000228451 Stevia rebaudiana Species 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000000905 isomalt Substances 0.000 claims 1
- 235000010439 isomalt Nutrition 0.000 claims 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims 1
- 239000000047 product Substances 0.000 description 58
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 23
- 235000000346 sugar Nutrition 0.000 description 19
- 239000007787 solid Substances 0.000 description 16
- 235000020357 syrup Nutrition 0.000 description 16
- 239000006188 syrup Substances 0.000 description 16
- 108010036940 Levansucrase Proteins 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 235000013336 milk Nutrition 0.000 description 12
- 239000008267 milk Substances 0.000 description 12
- 210000004080 milk Anatomy 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 235000005911 diet Nutrition 0.000 description 10
- 238000000855 fermentation Methods 0.000 description 10
- 230000004151 fermentation Effects 0.000 description 10
- 150000008163 sugars Chemical class 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 9
- 229960004106 citric acid Drugs 0.000 description 8
- 235000015165 citric acid Nutrition 0.000 description 8
- 230000037213 diet Effects 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000013355 food flavoring agent Nutrition 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 210000000813 small intestine Anatomy 0.000 description 6
- 244000225789 Cordyline australis Species 0.000 description 5
- 235000016071 Cordyline australis Nutrition 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000005755 formation reaction Methods 0.000 description 5
- 235000015203 fruit juice Nutrition 0.000 description 5
- 150000002772 monosaccharides Chemical class 0.000 description 5
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 4
- 229960005164 acesulfame Drugs 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 229940107161 cholesterol Drugs 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 238000010411 cooking Methods 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- -1 humidifiers Substances 0.000 description 4
- 235000015243 ice cream Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 235000019605 sweet taste sensations Nutrition 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000001099 ammonium carbonate Substances 0.000 description 3
- 235000021152 breakfast Nutrition 0.000 description 3
- 238000013375 chromatographic separation Methods 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 206010016766 flatulence Diseases 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 235000021092 sugar substitutes Nutrition 0.000 description 3
- MMYFQTWHKPSUDE-DLQNOBSRSA-N 1,6-kestotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO[C@@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 MMYFQTWHKPSUDE-DLQNOBSRSA-N 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 240000006766 Cornus mas Species 0.000 description 2
- 235000003363 Cornus mas Nutrition 0.000 description 2
- 206010017999 Gastrointestinal pain Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 2
- 244000290333 Vanilla fragrans Species 0.000 description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000012501 ammonium carbonate Nutrition 0.000 description 2
- 229940059913 ammonium carbonate Drugs 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- MMYFQTWHKPSUDE-UHFFFAOYSA-N bifurcose Natural products OC1C(O)C(CO)OC1(CO)OCC1C(O)C(O)C(COC2(CO)C(C(O)C(CO)O2)O)(OC2C(C(O)C(O)C(CO)O2)O)O1 MMYFQTWHKPSUDE-UHFFFAOYSA-N 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- 229940077731 carbohydrate nutrients Drugs 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 235000020186 condensed milk Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 235000011869 dried fruits Nutrition 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 235000021433 fructose syrup Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 235000013310 margarine Nutrition 0.000 description 2
- 239000003264 margarine Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 201000009868 osmotic diarrhea Diseases 0.000 description 2
- 208000028719 osmotic diarrheal disease Diseases 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- HQFMTRMPFIZQJF-MBBOGVHQSA-N (3r,4s,5s,6r)-2-[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]oxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O[C@@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O1 HQFMTRMPFIZQJF-MBBOGVHQSA-N 0.000 description 1
- FEGFCCDAEMWHCU-KCRUCZTKSA-N (4S,5R,6R)-2,4,5,6,7-pentahydroxy-2,4-dimethylheptan-3-one Chemical class C[C@](C(C(O)(C)C)=O)(O)[C@H](O)[C@H](O)CO FEGFCCDAEMWHCU-KCRUCZTKSA-N 0.000 description 1
- IPTFEYVXGRXKMB-IYDUGKLZSA-N (4s,5r,6r)-2,4,5,6,7-pentahydroxy-4,5-dimethylheptan-3-one Chemical compound CC(O)C(=O)[C@@](C)(O)[C@](C)(O)[C@H](O)CO IPTFEYVXGRXKMB-IYDUGKLZSA-N 0.000 description 1
- USWINTIHFQKJTR-UHFFFAOYSA-N 3-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C2C=C(S(O)(=O)=O)C(O)=CC2=C1 USWINTIHFQKJTR-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 240000004246 Agave americana Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 101100172871 Arabidopsis thaliana EXA1 gene Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 101150106671 COMT gene Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000003550 Eusideroxylon zwageri Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 241000533950 Leucojum Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 229940008309 acetone / ethanol Drugs 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229940006546 albon Drugs 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000019543 dairy drink Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000008131 glucosides Chemical group 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229960004717 insulin aspart Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- HQFMTRMPFIZQJF-UAEIHXJMSA-N neokestose Natural products OC[C@H]1O[C@@](CO)(OC[C@H]2O[C@@H](O[C@]3(CO)O[C@H](CO)[C@@H](O)[C@@H]3O)[C@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O HQFMTRMPFIZQJF-UAEIHXJMSA-N 0.000 description 1
- 239000000615 nonconductor Substances 0.000 description 1
- VOMXSOIBEJBQNF-UTTRGDHVSA-N novorapid Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 VOMXSOIBEJBQNF-UTTRGDHVSA-N 0.000 description 1
- 239000008203 oral pharmaceutical composition Substances 0.000 description 1
- 235000016046 other dairy product Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 229920000157 polyfructose Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000001060 yellow colorant Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/18—Carbohydrates
- A21D2/181—Sugars or sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/154—Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
- A23C9/1544—Non-acidified gels, e.g. custards, creams, desserts, puddings, shakes or foams, containing eggs or thickening or gelling agents other than sugar; Milk products containing natural or microbial polysaccharides, e.g. cellulose or cellulose derivatives; Milk products containing nutrient fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/346—Finished or semi-finished products in the form of powders, paste or liquids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/10—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products
- A23L21/12—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products derived from fruit or vegetable solids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L9/00—Puddings; Cream substitutes; Preparation or treatment thereof
- A23L9/10—Puddings; Dry powder puddings
- A23L9/12—Ready-to-eat liquid or semi-liquid desserts, e.g. puddings, not to be mixed with liquids, e.g. water, milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0051—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Fructofuranans, e.g. beta-2,6-D-fructofuranan, i.e. levan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
- A23G2200/06—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing beet sugar or cane sugar if specifically mentioned or containing other carbohydrates, e.g. starches, gums, alcohol sugar, polysaccharides, dextrin or containing high or low amount of carbohydrate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Materials Engineering (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Grain Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fodder In General (AREA)
Abstract
Branched fructo-oligosaccharides consisting of a chain which comprises mainly fructose units and has a preferred chain length of 2 to 15 units, on which are fixed one or more side chains mainly composed of fructose units. The length of the side chain, which may be straight or branched, is of 1 to 10 units. A composition consisting of one or more of the above mentioned branched fructo-oligosaccharides and, particularly, mixtures comprising, apart from the branched fructo-oligosaccharides, other ingredients such as proteins, lipids or fatty acids, carbohydrates, fibres and other additives, are also described.
Description
BRANCHED FRUCTO-OLIGOSACCHARIDES METHOD FOR
OBTAINING THEM AND USE OF PRODUCTS CONTAINING THEM
Subiect of the invention The present invention relates to branched fructo-oligosaccharides which particularly exhibit sweetening and bulking agent properties.
It also relates to the products which contain these branched fructo-oligosaccharides and to their use.
Finally, the present invention applies to the particular processes for their preparation.
Summary of the prior art A sedentary lifestyle where physical labor has nearly disappeared has considerably changed food require-ments.
As a general rule, too much is eaten and often in an unbalanced manner. Too much fat, too much salt, too few so-called slow (complex) sugars and too little fiber.
In particular, the proportion of so-called slow sugars in our diets has fallen considerably, thus limiting their energy contribution.
Currently, the so-called rapid sugars and fats supply the principal energy contributions in our diet . It has been known for a long time that an unbalanced diet leads in the long term to serious deficiencies or even to diseases, for example cardiovascular diseases.
Additionally, a diet which is poor in fibers seems to be the cause of many digestive system disorders.
There is increasing awareness of the close connection which exists between the general state of health and the eating habit. There is also a tendency to adapt the diet or more particularly the dietetics to individual needs.
Inter alia, the development and the use of sweeteners with a high sweetening power have allowed the consumer to better adapt his diet to his needs. These sweeteners make it possible to give a sweet taste to the foods which contain them without having to have recourse to high-calorie sugars.
In this way, beverages with a negligible calorie
OBTAINING THEM AND USE OF PRODUCTS CONTAINING THEM
Subiect of the invention The present invention relates to branched fructo-oligosaccharides which particularly exhibit sweetening and bulking agent properties.
It also relates to the products which contain these branched fructo-oligosaccharides and to their use.
Finally, the present invention applies to the particular processes for their preparation.
Summary of the prior art A sedentary lifestyle where physical labor has nearly disappeared has considerably changed food require-ments.
As a general rule, too much is eaten and often in an unbalanced manner. Too much fat, too much salt, too few so-called slow (complex) sugars and too little fiber.
In particular, the proportion of so-called slow sugars in our diets has fallen considerably, thus limiting their energy contribution.
Currently, the so-called rapid sugars and fats supply the principal energy contributions in our diet . It has been known for a long time that an unbalanced diet leads in the long term to serious deficiencies or even to diseases, for example cardiovascular diseases.
Additionally, a diet which is poor in fibers seems to be the cause of many digestive system disorders.
There is increasing awareness of the close connection which exists between the general state of health and the eating habit. There is also a tendency to adapt the diet or more particularly the dietetics to individual needs.
Inter alia, the development and the use of sweeteners with a high sweetening power have allowed the consumer to better adapt his diet to his needs. These sweeteners make it possible to give a sweet taste to the foods which contain them without having to have recourse to high-calorie sugars.
In this way, beverages with a negligible calorie
- 2 - PCT/BE91/00014 contribution have, for example, appeared on the market.
On the other hand, the use of bulking agents is often essential in a range of foods such as pastry, confectionery, etc.
Sucrose, or glucose or fructose syrups are usually used as bulking agents. Nevertheless, these sugars are highly calorific.
Again, "sugar substitutes" have appeared on the market which are characterized by a lower calorific contribution.
More particularly, the ideal bulking agent would be a low- or noncalorific natural product, which is safe to use, wholesome, well tolerated by the body, without any particular taste and which can be used in a similar way to sucrose.
The bulking agents meeting these requirements have a high commercial potential.
The bulking agents are low-calorie if they satisfy one of the two following conditions:
- of being only partially or not at all absorbed into the blood via the small intestine;
- o~ being absorbed into the blood via the small intestine but not metabolized or only slightly meta-bolized by the body.
The use of linear fructo-oligosaccharides as bulking agents is known. These sugars, whose natural presence in food has been known for a long time, can be obtained enzymatically (see Albon et al., J. Chem. Soc.
( 1953 ) , p. 24-27; Kawai et al . , Agr. Biol. Ghem. Vol . 37, No. 9 (1973, p. 2111-2119; Tomoda et al., Kyoritsu Yakka Daigaku Nempo vol. 20 (1975) p. 1-8) or by hydrolysis of inulin.
The linear fructo-oligosaccharides can be pro-duced industrially from sugar as described in the docu-ment GB-A-2000144 by obtaining products of GFn type (G = Glucose, F = Fructose, n = 2 to 5, bonds of the type B (1-2), or by hydrolysis of inulin, producing a mixture of GFn and Fn (n = 2 to 10 and more).
These fructo-oligosaccharides have the following ~~'~a~~.~~'~
On the other hand, the use of bulking agents is often essential in a range of foods such as pastry, confectionery, etc.
Sucrose, or glucose or fructose syrups are usually used as bulking agents. Nevertheless, these sugars are highly calorific.
Again, "sugar substitutes" have appeared on the market which are characterized by a lower calorific contribution.
More particularly, the ideal bulking agent would be a low- or noncalorific natural product, which is safe to use, wholesome, well tolerated by the body, without any particular taste and which can be used in a similar way to sucrose.
The bulking agents meeting these requirements have a high commercial potential.
The bulking agents are low-calorie if they satisfy one of the two following conditions:
- of being only partially or not at all absorbed into the blood via the small intestine;
- o~ being absorbed into the blood via the small intestine but not metabolized or only slightly meta-bolized by the body.
The use of linear fructo-oligosaccharides as bulking agents is known. These sugars, whose natural presence in food has been known for a long time, can be obtained enzymatically (see Albon et al., J. Chem. Soc.
( 1953 ) , p. 24-27; Kawai et al . , Agr. Biol. Ghem. Vol . 37, No. 9 (1973, p. 2111-2119; Tomoda et al., Kyoritsu Yakka Daigaku Nempo vol. 20 (1975) p. 1-8) or by hydrolysis of inulin.
The linear fructo-oligosaccharides can be pro-duced industrially from sugar as described in the docu-ment GB-A-2000144 by obtaining products of GFn type (G = Glucose, F = Fructose, n = 2 to 5, bonds of the type B (1-2), or by hydrolysis of inulin, producing a mixture of GFn and Fn (n = 2 to 10 and more).
These fructo-oligosaccharides have the following ~~'~a~~.~~'~
- 3 - PCT/BE91/00014 advantageous properties: neutral and sweet taste, absence of smell, low calorific. value, dietary fiber effect, bifidogenic effect and natural and nontoxic character.
Furthermore, these products have technological charac-teristics such that they can be used according to the standard methods for preparation of sugars and syrups.
Likewise, 'they can be used as sugar substitute in standard applications, for example as sweeteners in foods and beverages or as base materials or excipients for the preparation of pharmaceutical products.
Furthermore, they can be used in any industrial application envisaged for sugars and syrups, such as the production of adhesives, humidifiers, insecticides, colorants, tanning agents, electrical insulators, binders for foundry cores or, in a more general way, as softeners and/or thickeners and, of course, more particularly in the dietary field as a groduct of low calorific value or as a product with a dietary fiber effect or with a bifidogenic effect.
As a general rule, the low-calorie bulking agents are only partially absorbed in the small intestine and, for this reason, pass into the large intestine where they undergo, partially or totally, a fermentation due to the intestinal flora.
This is a natural process which all fibers undergo and which is the cause of the beneficial effect arising from the fibers.
The bulking agent is converted by fermentation in the large intestine into a range of reaction products of which the principal ones are volatile fatty acids (VFA) and gases such as COZ, HZ and, in certain cases, CH4.
These gases are principally removed by the blood and the lungs or, in part, by flatulence.
During the passage of the bulking agent through the small intestine, the molecules of the latter absorb water and pass into the large intestine. This can cause osmotic diarrheas when the bulking agent is taken in large quantities. Of course, this effect depends essen tially on the water-absorbing power of the bulking agent 2~~~~1.~'~
Furthermore, these products have technological charac-teristics such that they can be used according to the standard methods for preparation of sugars and syrups.
Likewise, 'they can be used as sugar substitute in standard applications, for example as sweeteners in foods and beverages or as base materials or excipients for the preparation of pharmaceutical products.
Furthermore, they can be used in any industrial application envisaged for sugars and syrups, such as the production of adhesives, humidifiers, insecticides, colorants, tanning agents, electrical insulators, binders for foundry cores or, in a more general way, as softeners and/or thickeners and, of course, more particularly in the dietary field as a groduct of low calorific value or as a product with a dietary fiber effect or with a bifidogenic effect.
As a general rule, the low-calorie bulking agents are only partially absorbed in the small intestine and, for this reason, pass into the large intestine where they undergo, partially or totally, a fermentation due to the intestinal flora.
This is a natural process which all fibers undergo and which is the cause of the beneficial effect arising from the fibers.
The bulking agent is converted by fermentation in the large intestine into a range of reaction products of which the principal ones are volatile fatty acids (VFA) and gases such as COZ, HZ and, in certain cases, CH4.
These gases are principally removed by the blood and the lungs or, in part, by flatulence.
During the passage of the bulking agent through the small intestine, the molecules of the latter absorb water and pass into the large intestine. This can cause osmotic diarrheas when the bulking agent is taken in large quantities. Of course, this effect depends essen tially on the water-absorbing power of the bulking agent 2~~~~1.~'~
- 4 - PCT/BE91/00014 and is, in general, higher in the case of substances based essentially on monosaccharides than in the case of saccharides with a higher degree of polymerization.
In particular, the linear fructo-oligosaccharides which are not absorbed or only slightly absorbed in the stomach and the small intestine are found almost entirely in the large intestine and, as a result of their oligo saccharide nature (low degree of polymerization), they cause osmotic diarrheas only when they are taken in large quantities.
However, when they are ingested in large quan-tities, the linear fructo-oligosaccharides can give rise to a variety of unpleasant consequences (and of dis-orders) due principally to their fermentable character:
increased flatulence, intestinal cramps, gastric noises, soft stools or even diarrheas.
More precisely, traces of linear fructo-oligo-saccharides are not found in stools, even when large quantities have been ingested: this shows that they have undergone complete fermentation by the intestinal flora.
In fact, it has been proved that the linear fructo-oligosaccharides are degraded by bacteria belong ing to the Bifidobacterium family, which shows the bifidogenic character of the linear fructo-oligo saccharides.
It is well understood that these various pheno-mena depend on the dose ingested, the sensitivity of the person concerned, the form in which the product contain-ing the fructo-oligosaccharides is given, the time span over which the amounts were ingested, possibly the period of adaptation to the product and the composition of the other ingredients and, finally, the nature of the bulking agent ingested.
Moreover, these are disorders which have been known for a long time, in particular during the ingestion of large quantities of plums, cherries or onions.
These undesirable side effects are the cause of the fact that the use of these low-calorie bulking agents is not unlimited.
In particular, the linear fructo-oligosaccharides which are not absorbed or only slightly absorbed in the stomach and the small intestine are found almost entirely in the large intestine and, as a result of their oligo saccharide nature (low degree of polymerization), they cause osmotic diarrheas only when they are taken in large quantities.
However, when they are ingested in large quan-tities, the linear fructo-oligosaccharides can give rise to a variety of unpleasant consequences (and of dis-orders) due principally to their fermentable character:
increased flatulence, intestinal cramps, gastric noises, soft stools or even diarrheas.
More precisely, traces of linear fructo-oligo-saccharides are not found in stools, even when large quantities have been ingested: this shows that they have undergone complete fermentation by the intestinal flora.
In fact, it has been proved that the linear fructo-oligosaccharides are degraded by bacteria belong ing to the Bifidobacterium family, which shows the bifidogenic character of the linear fructo-oligo saccharides.
It is well understood that these various pheno-mena depend on the dose ingested, the sensitivity of the person concerned, the form in which the product contain-ing the fructo-oligosaccharides is given, the time span over which the amounts were ingested, possibly the period of adaptation to the product and the composition of the other ingredients and, finally, the nature of the bulking agent ingested.
Moreover, these are disorders which have been known for a long time, in particular during the ingestion of large quantities of plums, cherries or onions.
These undesirable side effects are the cause of the fact that the use of these low-calorie bulking agents is not unlimited.
- 5 - PCT/BE91/00014 In particular, for certain agents, legislation has established a maximum daily dose. This dose amounts, for example, to 30 g for certain sugar alcohols (poly-alcohols derived from sugar).
Even in the case of bulking agents consisting of linear fructo-oligosaccharides, these disadvantages persist although the latter are in general better tolera-ted by the body, probably due to the fact that the osmotic effect is less than for certain sugar alcohols.
More particularly, it has become apparent that the long chain fructo-saccharides, such as inulin, cause osmotic phenomena which are less marked still. However, the negative effects due to fermentation by the intes-tinal flora have not completely disappeared.
Furthermore, these fructo-oligosaccharides exhibit a solubility which decreases and a viscosity which increases as the chain length increases.
The result of this is that the long chain fructo saccharides do not exhibit all the appropriate technological properties for use as bulking agents instead and in place of sugar.
Moreover, fructose polymers have already been described in the following documents:
- In Indian Journal of Biochemistry & Biophysics, vol.
13, Dec. 1976, pp. 398-419, Satyanarayana describes branched oligosaccharides which may be found in small quantities in nature. It seems that fructo syltransferase which is isolated from the vera Cruz agave is unable to synthesize this branched oligo saccharide; it is thus not possible to obtain it in large quantities.
- Likewise, in Liebigs Annalen der Chemie, 614, 126 (I958), Schlubach described branched oligosaccha rides which can be found in small quantities in nature.
- In Liebigs Annalen der'Chemie, 635, 154 (1959), Schlubach also described natural products consisting of polymerized and branched fructose units which cannot be obtained naturally in large quantities.
Even in the case of bulking agents consisting of linear fructo-oligosaccharides, these disadvantages persist although the latter are in general better tolera-ted by the body, probably due to the fact that the osmotic effect is less than for certain sugar alcohols.
More particularly, it has become apparent that the long chain fructo-saccharides, such as inulin, cause osmotic phenomena which are less marked still. However, the negative effects due to fermentation by the intes-tinal flora have not completely disappeared.
Furthermore, these fructo-oligosaccharides exhibit a solubility which decreases and a viscosity which increases as the chain length increases.
The result of this is that the long chain fructo saccharides do not exhibit all the appropriate technological properties for use as bulking agents instead and in place of sugar.
Moreover, fructose polymers have already been described in the following documents:
- In Indian Journal of Biochemistry & Biophysics, vol.
13, Dec. 1976, pp. 398-419, Satyanarayana describes branched oligosaccharides which may be found in small quantities in nature. It seems that fructo syltransferase which is isolated from the vera Cruz agave is unable to synthesize this branched oligo saccharide; it is thus not possible to obtain it in large quantities.
- Likewise, in Liebigs Annalen der Chemie, 614, 126 (I958), Schlubach described branched oligosaccha rides which can be found in small quantities in nature.
- In Liebigs Annalen der'Chemie, 635, 154 (1959), Schlubach also described natural products consisting of polymerized and branched fructose units which cannot be obtained naturally in large quantities.
- 6 -In Agric. Biol. Chem., 52(4) 1303-1304 (1988), Muramatsu describes how oligosaccharides whose structure is identical to the products described in the patent EP-0307158 are obtained From sucrose via a microorganism.
- In Carbohydrate Research, 180 (1988), 315-324, Brasch et al.
described a .fructose polymer (average chain length: 18) where 15% of the fructose units contain a branching point at t:he Oj6 position.
Nevertheless, as a result of their excessively great chain length, these r~lecules do not constitute a suitable bulking agent.
- The patent EP-0,307,158 of Nihon Shokuhin descr_i.bes a fructose poly~r where a branching point appears on a glucose unit.
- The document J. of Chem. Soc., p. 1822-1830 (1951) describes a branched polyfructose, wherein the number of fructose units are estimated between 18 and 30 units.
- The document TLi.ebigs annalen der Chemie, 647, 41 ( 1961 ) describes fxucto-oligosaccharides which present either a single branch upon the glucose unit (the neokestose or the neobifuncose series), or a single branch upon a fructose unit (the kestose, the bifurcose or the phlein derivatives of the bifurcose).
- The docui~nt New Zealand J. of Thechnologie, vol. 1, N° 1, p. 27-31 (1985) describes a branched fructo-oligosaccharide extracted from "cordyline australis" with an average chain length of 18 units.
- The patent application GB-2 105 338 describes an enzymatic treatment process allaaing the obtention of a non-branched oligosaccharide constituted of one to four fructose molecules linked to a sucrose molecule.
Aims of the invention The present invention aims to produce bulking agents which do not exhibit or which exhibit in a greatly abated way, the undesirable digestive disorders due to the conventional bulking agents.
Another aim of the present invention is to supply a bulking agent which exhibits the same advantageous properties as the linear fructo-oligosaccharides, such as neutral and sweet tastes, absence of smell, low calorific value, dietary fiber effect, bifidogenic effect and natural and nontoxic character of the product.
Another aim of the present invention consists in producing products which are more soluble.
Another aim of the present invention consists in supplying products which can be used in a conventional way, using the standard processes for preparing sugars and syrups.
Other camplementaxy airs of the present. invention ie in -the use of the product of the invention as a sweetener, as a low-calorie or weakly cariogenic food, as a bifidogenic product or a produces with a REPhACEMENT SHEET
fiber effect, as a means of lowering the cholesterol level or of improving the condition of the intestinal flora, etc.
Other aims and advantages will become apparent in the description which follows.
Description of the invention The present invention relates to branched fructo-oligosaccharides consisting of a main chain and of one or more side chains, characterized in that the main chain and the side chains) consist mainly of fructose units, the main chain contains from 2 to 15 units and at least one branching point on one fructose unit, the branching of said at least one branching point consisting of a fructose-fructose bond, with the exception of the natural products.
The present invention also relates to a c~sition consisting-of one or mare branched fructoroLigosaccharides according to the invention and, more particularly, to mixtures consisting, in addition to the branched fructo--oLigosarchar~.de ( s ) , of other ingredients such as Pr~~~ ~-i-Pig or fatty acids, carbohydrates, fibers and other additives. -In particular, these ingredients may be products taken frcsn the following nonlimiting list: sweeteners such as saccharose, products of the hydrolysis of the starch, palatinose, sucrose, glucose, fructose, glucose syrups or polyalcohols derived fran sugar such as sorbitol, xyLitol, erythritol, mannitol, maltitol, lactitol or :isan~lt~ leucritol;
bulking agents such as polydextrose, cellulose, hemicellulose or fructoroligosaccharides; or, again, s~a~eeteners with a high sweetening power such as aspartame, acesulfame, saccharin, stevioside, sucralose and other dipeptide sweeteners, etc.
The products according to the invention are particularly suitable for use in human or animal feeding as bulking agents, as sweeteners, as low-calorie or weakly cariogenic foods, as bifidogenic prod~u~cts or products which improve the intestinal flora, as products with a dietary fiber effect, as agents for reducing the cholesterol 3 0 l~- ~. again, to improve the tolerance of food products. Zhe present invention relates also to a pharmaceutical cat~osition comprising a branched fzvcto-oligosar_chari~de accor<lir~g to the invention and possibly a suitable carrier.
Finally, the present invention also relates to processes for preparing these branched fructoroLigosaccharides.
-7a-In nar+;cular, the products according to the invention can be obtained by synthesis from sugar or fran mixtures of fructose, optionally through the intexmedi.acy catalysts or enzymes or by interaction of various enzymes with the sucrose of the fructo-oLigosaccharides, inulin or fructans or chemically, that is to say by polymerization, principally of fructose, or by extraction frcm vegetable sources containing the said fructans, or, 2~~~61~~
again, by hydrolysis of branched fructose polymers.
The fruc-to-oligosaccharides according to the invention can, in particular, be obtained from sucrose, fructose syrups, fructose in the crystalline form, fructans, levans, inulin, their hydrolysis products or, finally, products extracted from plants containing fructans.
Through the intervention of various enzymes, such as for example fructosyltransferase, levansucrase, etc., it is also possible selectively to form bonds which make it possible to implant fructose units at specified positions on other fructose units in the oligosaccharide chains. Enzymes may be used either consecutively or simultaneously. Preferably, enzymes will be used which preferentially form different bonds from those of the substrate.
For the production of branched fructo-oligo saccharides, optionally enzymatic processes of condensa tion or of synthesis, or, again, hydrolytic processes may be used.
By condensation of fructose monomers, it is possible to obtain an "at random" polymerization which may be followed by a chromatographic separation.
It is also possible to obtain branched fructo oligosaccharides by hydrolysis of synthesized branched molecules or of those which exist in the natural state.
In this case, it is also possible to use several different hydrolysis techniques, especially the technique of acid hydrolysis, the technique of alkaline hydrolysis or the technique of enzymatic hydrolysis.
In particular, specific enzymatic hydrolysis such as, for example, the interaction of endoinulase with the mixture of branched fructans isolated from Cordyline australis ("cabbage tree"), which specifically attacks the (i(2~1) bonds, gives rise to branched fructo-oligo-saccharides.
The result depends on the nature of the starting material and on the hydrolysis technique used and, optionally, the enzymes used for the hydrolysis process Y C
and the reaction conditions. According to the reaction conditions, new branching points may be produced during the hydrolysis reaction of branched or linear molecules.
Reducing end groups can, in addition, be chemi tally converted, for example by oxidation, by reduction or by hydrogenation, etc.
The present invention also relates to a process which makes it possible to render the ir~ulin more soluble by a very incomplete hydrolysis, followed by a branching reaction.
The processes used and the products obtained are better described with the help of the examples which follow.
Example 1: Preparation of branched fructan polymers by hydrolysis A mixture of branched fructans can be obtained from the "cabbage tree" (Cordyline australis) by extrac-ting with methanol, washing with water followed by precipitation in an acetone/ethanol solution and drying.
The substances obtained consist principally of glucose and fructose units in a ratio of 1 to 16, arranged in chains with an average degree of polymeriza-tion equal to 18, where approximately 15$ of the fructose units have a branching point.
A 25° Brix solution is heated to 90°C and then 2N HC1 is rapidly added until a pH of 2.5 is obtained.
After reacting for 2 minutes, the hydrolysis is stopped by adding NaOH (3M) until a pH of 6.5 is obtained.
This solution is then filtered and demineralized by a double treatment on cationic and anionic ion exchangers. The glucose, the fructose and the sucrose formed by hydrolysis are then removed by chromatographic separation on a cationic column in the potassium form.
The mixture of oligosaccharides thus obtained contains between 5 and 10~ of mono- and disaccharides and from 90 to 95~ of oligosaccharides. The average degree of poly-merization of the composition thus obtained is approxi-mately 5 and approximately 40~ of the molecules therein are branched.
ExAMPLE 2: Preparation of the product according to the invention by synthesis In this case, the enzyme levansucrase, derived from Bacillus subtilis, is used.
It has been observed that 'this enzyme, when incu-bated under suitable conditions in the presence of sucrose and of fructo-oligosaccharides of the p(2-~1) type, forms branched fructo-oligosaccharides.
In this example, the base fructo-oligosaccharides used are obtained by enzymatic hydrolysis of inulin by endo-inulinase obtained from the enzymatic preparation Novozyme 230.
A 40° Brix solution consisting of 50~ sucrose and 50$ base fructo-oligosaccharides is prepared in a 0.05M
phosphate buffer solution at a pH of 6.
A solution of levansucrase which contains 20 U/ml - 1 U being the quantity of enzyme necessary to release 1 micromole of glucose per minute - is added to the mixture in such a way as to obtain 4 U of levansucrase per gram of dry carbohydrate matter in the mixture. The solution is then incubated at 30°C for 18 hours in an orbital shaker (150 rev/min). The enzymatic reaction is then halted by cooking the reaction mixture for 5 minutes. Linear, long chain p-fructans (DP>12) are separated off by precipitating with 80~ ethanol.
After centrifuging (30 minutes at 5000 rev/min) and evaporating off the ethanol under vacuum, the solu-tion is demineralized on ion exchangers such as described in Example 1.
Th2 mixture obtained is then subjected to a chromatographic analysis. The chromatogram is represented in Figure 1.
The reaction mixture contains at this point approximately 27$ glucose, 3~ fructose, 3~ sucrose and 67~ fructans with a DP>2, of which approximately 60~ has a DP<12 and 40~ has a DPzl2. This fraction with a DPzl2 cannot be precipitated with 80~ ethanol, which is an indication of its branched nature. Approximately 40~ of the molecules which have a DP of 3 to 12 are branched 2~'~~~~~~f {cf. chroma.togram Figure 1).
The monosaccharides are principally removed by chromatographic separation.
The final product thus obtained contains approxi matel.y 90 to 95% of oligosaccharides with an average degree of polymerization equal to 4.5-5 and where X10 to 50% of the molecules are branched.
The branched fructo-oligosaccharides exhibit unexpected tolerance properties while still retaining the other advantageous properties of linear fructo oligosaccharides: neutral and sweet taste, absence of smell, low calorific value, dietary fiber effect, bi.fido-genic effect and natural and nontoxic character.
The branched fructo-oligosaccharides can also be used as sugar substitutes in all the standard and indus trial applications described for linear frucao-oligosacc harides.
The improved tolerance of these branched fructo--oligoposaccharides was demonstrated by carrying out the following in-vitro and in-vivo tests:
1. IN-VITRO Tests Fresh fecal materials from male subjects in good health were homogenized with 5 times their caeight of isotonic NaKCl in an anaerobic environment. Five 10 ml aliquot fractions of this homogenized mixture were used per test group.
As reference test group, 5 incubations were carried out in test tubes containing 20 g~l of a mixture of fructo-oligosaccharides consisting of 5% of glucose, fructose and sucrose, 35% of GF2, 50% of GF3 and 10% of GF4 (G = glucose, F = fructose).
As second test group, 5 incubations were carried out in test tubes containing 20 ml/1 of the mixture of branched fructo-oligosaccharides described in Example 1.
The test tubes are sealed with a sheet of paraf-fin wax whose displacement indicates the production of gas.
The formation of gas was monitored for 12 hours.
It is expressed in centimeters of displacement per hour.
R~P~AC~ra~rrx sH~ET
~~~o~~'l These tests show that the formation of gas per hour in the case of branched fructo-oligosaccharides reaches only 35~ of that dine to linear fructo-oligosaccharides.
2. IN-VIVO Tests During an experiment carried out on three male subjects sensitive to fermentation in the large rotes-.
tine, various quantities of fructo-oligosaccharides were mixed in fruit juices taken at breakfast, this breakfast usually consisting o.f fruit juice, bread and coffee in the usual quantities. The dose introduced is gradually increased in 10 g doses from an initial dose also of 10 g. Between two test breakfasts, at least two days elapse without any test.
The reactions of the subjects were recorded for each concewtration and more specifically as regards the following criteria: flatulence, gastric noises, intes-tinal cramps, soft stools and diarrhea. The "stopping dose" is defined as the first dose where one or more of these side effects are felt to be uncomfortable.
The substances tested which were introduced into the fruit juice are the following:
substance A: mixture of linear fructo-oligosaccharides such as described above in the prior art;
substance B: mixture of branched fructo-oligosaccharides such as described in Example 2.
Substance C: mixture containing 505 of substance A and 50~ of substance B.
The results obtained are dP~r~r;hA~a ;" ,-,", following table:
STOPPING DOSE A B C
VOLUNTEER 1 20 g 40 g 30 g VOLUNTEER 2 30 g 60 g 50 g VOLUNTEER 3 40 g 60 g 50 g From this table, it can be concluded that the branched fructo-oligosaccharides are tolerated better than the linear oligosaccharides and that by introducing a certain quantity of branched fructo-oligosaccharides into a mixture which also comprises linear fructo-oligosaccha.rides, the tolerance of this mixture is increased.
Properties Low-calorie product The branched fructo-oligosaccharides are not hydrolyzed by human digestive enzymes. These substances thus have a low calorie contribution.
Weakly cariog_enic product The branched fructo-oligosaccharides are less cariogenic than sucrose. This is explained by the fact that they are not used as substrate for the formation of dental plaque and that they are less capable of causing the formation of acid by the oral flora.
Products with bifidoQenic activity and which improve the intestinal flora The branched fructo-oligosaccharides have a selective bifidogenic effect: they stimulate in a speci-fic way the growth of the bifid population in the large intestine. This is explained by the fact that these fructo-oligosaccharides are used as an energy source by the bacteria belonging to the Bifidobacteria group, whereas other bacteria are much less able to use this substrate. In particular, a certain number of putref-active bacteria (such as Salmonella and Clostridium) have their growth limited, which brings about a qualitative and quantitative improvement in the intestinal flora.
Product with dietary fiber effect and which reduces the cholesterol level The fructo-oligosaccharides have a dietary fiber effect: they reduce the intestinal transit time and increase the fecal mass. This is explained by the fact that these fructo-oligosaccharides are not absorbed in the small intestine and pass into the large intestine where they undergo a fermentation. These fructo-oligo-saccharides also cause a reduction in the blood chole-sterol level as a result of their dietary fiber effect.
Diuretic agent The branched frueto-oligosaccharides can be used for the 2~~~~~ ~~
prevent ion or the treatment of al.l those disorders which may be caused by the presence of products such as, for example, accumulated degradation products which can be the cause of kidney disorders, liver disorders or of cancer, etc.
Product which improves the tolerance of other products It is already known that branched fructo-oligo-saccharides are tolerated better than their linear analogs.
Indeed, the branched molecules constitute fermen-tation substrates which are more difficult for the intestinal flora; the fermentation is thus retarded by the presence of these molecules.
It is thus possible to improve the tolerance of fermentable foods by adding branched fructo-oligo saccharies to the diet, due to the reduction and slowing down of the fermentation phenomena.
Solubility of the product The branched fructo-oligosaccharides have a higher solubility than that of the linear compounds, which allows them to be used more readily in a certain number of products (cold sparkling or dairy drinks, other dairy products, confectionery, biscuits, etc.j where high concentrations of sugars must be used.
The combination of these last two properties, namely the increased tolerance of the branched fructo-oligosaccharides and the increased solubility of the product according to the invention favor their use as bulking agents.
Increased stability in acids medium The branched fructo-oligosaccharides have better stability in acidic medium than the linear compounds, and this makes it possible to limit their degradation ( forma-tion of saccharides such as fructose, glucose and sucrose) during the manufacture and the storage of acidic foods and to guarantee that the latter have characteris-tics which are more constant during their lifetime.
The increase in the stability in acidic medium was revealed during a comparative experiment carried out with two substances:
Substance A: mixture of linear fructo-oligosaccharides containing 5~ of glucose, fructose and sucrose 35~ of GF2 50~ of GF3 10~ of GF4 Substance B: mixture of branched fructo-oligo-saccharides as described in Example 1~
Each of 'the substances A and B was taken up in 10 ° Brix aqueous solution; the pH was then ad justed to 3.5 with the aid of hydrochloric acid.
The solutions thus obtained were stored for several weeks at 20°C. The stability of the fructo oligosaccharides in these solutions was followed by the development of glucose and sucrose contents {determined by gas chromatography) during storage.
The results obtained are described in the table below:
Table: Fructose, glucose and sucrose content in ~
Storage time Substance at 20 A B
C and pH = 3.5 4 weeks 18 11 8 weeks ~ 32 21 Applications The branched fructo-oligosaccharides can be incorporated into foods or prepared in the form of granules or tablets. In the latter case, they can be used as oral pharmaceutical compositions, for example to selectively stimulate the growth of the bifid population, as a diuretic, etc.
The frudto-oligosaccharides have properties comparable to those of sugar and glucose syrups; they can therefore be used in the same way. They can replace sugar and glucose syrups in the majority of applications, . CA 02076647 2000-03-30 especially in the following products:
- confectionery (sweets, etc.), - jelly products (gums, etc.), - chocolate-based preparations, - chewing gum, biscuits, .
- ice creams and sorbets, -- dairy products, ' - fruit-based drinks, - fruit jams and preparations, caramels, - phanaaceutical preparations, etc.
The branched fructo-oligosaccharides have, in particular, suitable properties for replacing sugar and glucose syrups in the preparation of low calorie, weakly cariogenic, bifidogenic and/or diet products.
The present invention ~is illustrated by a non-limiting range of examples of possible applications.
As base product, a syrup of branched fructo oligosaccharides, prepared as described in Example 1 or Example 2, was used.
The products according to the invention were evaluated by a panel of about twenty tasters in order to compare their properties with those of conventional products based on sucrose and/or glucose syrup. These tests revealed a high acceptance of products based on branched fructo-oligosaccharides.
EXAMPLE 3: Preparation of a milk ice cream Ingredients (by weight):
Skimmed milk powder 13.00 Water 62.46 Cream (35% fatty matter) 8.60 Branched fructo-oligosaccharides of 15.00 Example 1 Stabilizer (Cremodan SE30~ Grindsted 0.50 Products ) Vanilla flavoring agent (Silesia 0.40 111/8309280)~
Aspartame (NutraSweet)~ 0.04 ~
Composition:
Total solids 28.5%
Milk solids 16.0%
Milk fats 3.0%
Preparation:
The various ingredients in powder form are mixed While dry and dissolved in water.
The branched fructo-oligosaccharides, the flavor ing agent and the cream are then added. The whole is mixed until a homogeneous product is obtained.
The mi::cture is heated to 80'C and this tempera-ture is maintained for 30 seconds . The mixture is then homogenized while hot (mixer) , cooled to 5'C
and lE:ft to stand for a few hours in the refrigerator. It is aerated (100%) and frozen in an ice cream making machine (Carpigiani)~
It is stored in a deep freeze.
~XAMpLE 4: Preparation of a sorbet Incredients (by weight):
' Strawberry purEe (6.5% solids) 74.48 Branched fructo-oligosaccharides of 25.00 Examples 1 Stabil:Lzer (Fructodan SL64~ Grinsted 0.45 Products) Aspartame (NutraSweet) 0.07 Composition: 2:i% solids.
reparation:
The ingredients are thoroughly mixed, heated to 80'C and held at this temperature for 30 seconds.
The mixture is then cooled to 5'C and kept in the refrigerator for a few hours . It is aerated ( 75% ) and frozen in an ice cream making machine ( Carpigiani ) It is stored in a deep freeze .
EXAI~LE 5: Preparation of a iam Ingredients (by weight):
Strawberries (10% solids) 65.00 Branched fructo-oligosaccharides of 42.00 Example 1 ~
..
~ , WO 91/13076 - 18 - PCT/BE91/00014 Water 25.00 Pectin (LM 27NH95~ Sanofi Bio-Industrie) 1.00 Citric: acid ( 50% ) 0 . 80 Comvosition: 40% solids.
~regaration:
The pectin is dissolved in warm water ( 60'C) , and it is then thoroughly mixed with the straw berriea. The mixture is left to cook, with thorough stirring, until a product with a weight of 57 g is obtained.
The branched fructo-oligosaccharides, heated to 60'C, are then added. The citric acid is then added.. The mixture is allowed to cool to 75'C and is packed into glass jars.
EXAMPLE 6: Pre~earation of a yo hurt Ingredients (by weight) Whole milk (3.7% fatty~matter) 94.10 Skimms:d milk powder ~ 1.90 Yoghurt fermenting agents 1.00 Branched fructo-oligosaccharides of 3.00 Example 1 Composition:
Total solids 16.0%
Milk solids 13.5%
25~ Milk fats 3.5%
preparation:
The milk powder and the branched fructo-oligo-saccharides are mixed with the cold milk. The mixture is then heated to 6 0' C and homogenized .
3CI It is. then heated to 90'C and held at this temperature for 10 minutes.
The mixture is cooled to 45'C and is seeded with lactic fermenting agents. The mixture is trans ferred into preheated pots and incubated at 43'C
3:i to a ;pH o f 4 . 2 .
The product is stored at 10'C maximum.
~ WO 9I/13076 - 19 - PCT/BE91/00014 EXAMPLE 7: Preparation of a fruit cake Ingredients (by weight) Branched fructo-oligosaccharides of 25.30 Example 1 Margarine 8.50 Whole eggs 10.10 Ammonium carbonate/bicarbonate 0.40 Flour ~ 33.65 Milk 6.80 Raisins 10.10 Dried fruit 5.10 Acesulfame R ~ 0.05 Preparation:
Mix the branched fructo-oligosaccharides with the margarine, add the eggs, and the ammonium car bonate, the Acesulfame K and the bicarbonate dissolved in 0.5 liter of milk. Add the flour and the teat of the milk. Mix until a homogeneous mixture is obtained . Then add the rais ins and the dried fruit. Transfer the whole into a mold and bake in an oven at 250'C.
EXAMPLE 8: Preparation of a sponge cake Ingredients (by weight):
Branched fructo-oligosaccharides of 27.00 Example 1 Eggs 49.80 Flour 27.00 Butte=' 8.30 Acesul,fame K~(Fioechst) 0.05 Preparation:
Beat the branched fructo-oligosaccharides and the whole eggs in a bain-marie until a thick foam is obtained which has a density of t0.?5.
Sift the flour and add it to the paste while mixing~~ gently. Heat the butter until it is half melted and mix it with the dough. Pour the dough into a pregreased mold and cook in the oven for 20 minutes at 175'.
ERAI~LE 9: Preparation of cams Ingredients (by weight):
Branched fructo-oligosaccharides of 94.00 Example 2 Gelatin 200 BLS ~(Sanofi Bio-Industrie) 6.50 Water 13.50_ 50% citric acid solution 1.50-Cola LE 1613 ~(Sanofi Bio-Industrie) 0.10 Aspartame 0.26 Solids content of the finished product: 80%.
Preparation:
The gelatin is dissolved in hot water (80' to 90'C). The branched fructo-oligosaccharides are cooked at 115'C. The syrup is then cooled to 100'C. The gelatin solution is then added to this syrup. The air bubbles are removed from this syrup by bringing it under vacuum or by leaving it to stand.. The mass is cooled to approximately 80°C. The flavoring agent, the colorant, Aspartame and citric acid are added and the mixture is poured into starch molds. The starch is used at a temperature of approximately 30'-35'C. The gums ate covered with a starch . layer and are left to stand for 24 hours at room temperature. The powder is then removed from the gums and the latter are coated with oil.
~,XAMPLE 10: preparation of hard cams ~nqredients (by weight):
Branched fructo-oligosaccharides of 96.50 . Example 2 Gelatin GAT 15 ~ 11.00 Water 16.50 50% citric acid solution 1.50 Mandarin flavoring agent LE 1450~(Sanofi 0.25 Bio-Industries) Aspartame,~ . ~ 0.28 Solids content of the finished product: 88%.
~revaration:
The gelatin is dissolved in hot water (80'-90'C) .
~ WO 91/13076 - 21 - PCT/BE9I/00014 The branched fructo-oligosaccharides are cooked at 113''C. The syrup is then cooled to 100'C. The gelatin solution is then added to this syrup. The air bubbles are removed from this syrup and the mass is cooled to approximately 80'C. The flavor-ing agent, the colorant, Aspartame and citric_ acid are added. The mixture is poured into starch .
molds. The starch is used at a temperature of approximately 30'-35'C.
The gums are covered with a starch layer.
They a:re left to stand in a ventilated oven for ? 2 hours at 5 0' C . The powder is then removed from the gums and the latter are coated with oil.
EX,AI~LE 11: preparation of hard sweets Ingredients (by weight):
Branched fructo-aligosaccharides of 125.00 Example 1 Citric acid (100%) 0.83 Extract HE4017~(Sanofi Bio-Industrie) 0.10 Lemon :Flavoring agent LE 1616~(Sanofi~ 0.15 Bio-Industrie) Acesul:fame K ~ 0 . 34 Solids content of the finished product: 98%.
,Preparation: , The branched fructo-oligosaccharides are heated at a temperature of 165'C until a solids content of 98% is obtained.
. The syrup is cooled to a temperature of t110'C;
the colorant, the flavoring agent, Acesulfame R
and citric acid are then mixed with the product obtained. The product obtained is then poured into molds . After cooling, the sweets are removed from the molds.
EXAI~LE 12: Preparation of caramels ~nqredients (by weight) Branched fructo-oligosaccharides of 68.60 Example 1 Sweetened condensed milk 26.00 Fat melting at 32'C 5.20 ' WO 91/13076 - 22 - PCT/BE91/00014 Salt 0.20 Lecithin 0.20 Acesul:Eame R. ~ 0 .24 Preparation:
Dissolve the lecithin in the fat in a bain-marie at 70'C.
Pour the branched fructo-oligosaccharides, the~-sweetened condensed milk, the salt, Acesulfame R
and the mixture consisting of fat and lecithin into a cooking pot. Mix and heat the mixture to 55-60'C.
Raise the temperature to 119-121'C. Then pour onto a cooling tray and allow to cool to 35-40'C.
EXA1~LE 13: Preparation of a_puddinq Ineredients (by weight):
Skimmed milk 84.94 Skimmed milk powder 1.80 - Branche:d fructo-oligosaccharides of 10.00 ExamplE: 1 Aspart~une (NutraSweet)~ 0.03 Starch (Snowflake 06304~ Cerestar) 3.00 Carrageenan (Genulacta SGI-1 ~ Hercules) 0.20 vanilla flavoring agent (Flav-o-lok 0.02 630019H ~ PFW Products) Cream-yellow colorant (51798,.Ned. 0.01 Kleurstofindustrie) Comt~ositions 20% solids .
Preparation:
The ingredients in powder form are mixed while dry; the cold milk is then added. The ingredients are then mixed until a homogeneous mixture is obtained.
The mixture .is heated to 95'C and is held at this temperature for 5 minutes.
The whole is cooled to 50'C while stirring the mixture. The mixture is packed into dishes and stored in the refrigerator.
~X,AI~LE 14: Preparation of a fruit-based drink Ingredients (by Weight):
Concentrated fruit juice (Orange PG31332 ~ 3.80 Quest Int.) Branched fructo-oligosaccharides of 7.00 Example 1 Sucrose 7.50 Citric acid (50%) 0.30 Water 81.40 Composition:
Solids 14.5%
Fruit juice 15.0%
Freoaration:
Dissolve the sugar in the water . Add the other ingredients and mix thoroughly. Store in the refrigerator.
Examgle 15: Enzymatic treatment of inulin A 40 Brix solution, consisting of 50% sucrose and 50% inu.lin, which contains a large proportion of molecules with a high degree of polymerization (DP), 3.s adjusted to a pH of 5.4. This solution is divided into two fractions.
A solution of levansucrase (LS) is added to the first ;fraction so as to obtain 2 U of levan sucrase per gram of solid while bringing the pH
to 5. The solution is then incubated at 37'C for 18 hours. The enzymatic reaction is then halted by cooking the reaction mixture for five minutes .
0.6 U o~f endoinulase, obtained from the enzymatic preparation of Novozyme 230, per gram of solid is added i:o the second fraction. The incubation is halted after one hour by cooking the reaction mixture: for five minutes. A solution of levansucrase is then added as described above.
The percentage of precipitation in an 80% ethanol solution is determined for the various fractions 2~~~~~j.~'~
~ of precipitate calculated for all the products with DP > 2 Base solution 66 Base solution + LS 40 Base solution + endoinul. 15 Base solution -f endoinul. + LS 2.5 This shows that the action of l.evansucrase has a significant effect on the solubility of linear carbo-hydrates of the inulin type. It is evident that other linear chains, e.g. based on 2>6 (phlein type) bonds can also be branched by using a suitable enzyme, which preferentially forms other bonds than those of the linear chain such as, for example, of the 2-~l type (fructosyl transferase). This technique could even be applied to glucoside chains.
By starting from an inulin with a mean DP
markedly lower than that used in the example, e.g. by starting from the inulin of Jerusalem artichoke, levan sucrase can be made to act directly on the inul.i.n without prior hydrolysis.
In tabular form, the gas phase chromatographic analysis of the various fractions. As can be seen from this table, an increase is recorded in the proportion of products with DP 5, DP 6, DP 7, DP 8, DP 9 and DP 10 and of soluble products which it was not possible to separate by means of the column used (DP 10+). In addition, it is possible to see on the chromatogram that the shape of certain peaks of the reaction product is different from the peaks of the starting material (the presence of a shoulder, showing the presence of two products) and that, in addition, other products have been formed which can no longer be found in the chromatogram of the levan. This clearly shows that levansucrase has transferred fructose molecules from the sucrose to the linear chain.
Glucose is then removed from the fraction which was treated with endoinulase and levansucrase by fermen-tation. The product thus obtained is permethylated by following the slightly modified method described in the paper by Goran Larson et al.: ~~Application of a simple REPLACEMENT SHEET
rnethylation procedure for the analysis of glycosphingo-lipids", published in Carbohydrate Research, Vol. 161, p.
2$1-290 (1987).
After the permethylation,, the hydrolysis which makes it possible to produce monosaccharides and the silylation of 'the monosaccharides, the latter are sepa rated into dimethyl-, trimethyl- and tetramethylfructoses by gas phase chromatography. The presence of dimethyl fructose in the chromatogram is proof of the presence in the saccharide chains of fructose molecules bonded to three other molecules. In addition, it is possible to detect isomers of trimethylfructose such as 3,4,6- and 1,3,4-trimethylfructose which indicates the presence in the molecules of 1-»2 and 2-~6 bonds. This clearly proves that the action of levansucrase on the linear chain of the inulin gives rise to branching points both of the type:
Frul 2Fru1 2Fru 2Fru and of the type:
Frul 2Fru6 2Fru Table I which follows shows the result of the gas phase chromatographic analysis of the various fractions of the products of Example 15.
I
TABLE I
INULIN+SUCROSE A+I~SA+ENDO lhr B+LS
{50/50) {A) (B) Fructose 1.3 4.8 1.4 3.6 Glucose 0.45 28 0.5 26.4 Sucrose 49.7 9.5 51.4 4.6 DFA 0.2 0.3 0.3 0.2 F2 0.4 0.2 0.4 0.3 GF2 1.3 0.6 1.3 0.8 F3 1.6 0.01 6.5 2 GF3 1.8 0.7 2 1 F4 1.0 0.1 5.5 4.5 GF4 2 0.9 4.3 1.6 F5 0.4 2.4 3 4,9 GF5 1.8 0.9 3.7 2.5 F6 0.3 0.2 2 3.2 GF6 1.4 1 3 2.9 F7 0.1 0.1 1.:.~ 2.7 GF7 1.2 1.1 1.2 3 F8 0.1 0.2 0.3 2.3 GF8 1 1.3 0.6 2.8 F9 0.05 0.1 0.2 DP10 0.2 1.1 0 1.8 DP10+ 0 22 3.8 27 Precipitate 33 23.5 7.1 1.7 (DFA = Di-Fructose Anhydride) ItEPLAGEMEP1T SHEET
- In Carbohydrate Research, 180 (1988), 315-324, Brasch et al.
described a .fructose polymer (average chain length: 18) where 15% of the fructose units contain a branching point at t:he Oj6 position.
Nevertheless, as a result of their excessively great chain length, these r~lecules do not constitute a suitable bulking agent.
- The patent EP-0,307,158 of Nihon Shokuhin descr_i.bes a fructose poly~r where a branching point appears on a glucose unit.
- The document J. of Chem. Soc., p. 1822-1830 (1951) describes a branched polyfructose, wherein the number of fructose units are estimated between 18 and 30 units.
- The document TLi.ebigs annalen der Chemie, 647, 41 ( 1961 ) describes fxucto-oligosaccharides which present either a single branch upon the glucose unit (the neokestose or the neobifuncose series), or a single branch upon a fructose unit (the kestose, the bifurcose or the phlein derivatives of the bifurcose).
- The docui~nt New Zealand J. of Thechnologie, vol. 1, N° 1, p. 27-31 (1985) describes a branched fructo-oligosaccharide extracted from "cordyline australis" with an average chain length of 18 units.
- The patent application GB-2 105 338 describes an enzymatic treatment process allaaing the obtention of a non-branched oligosaccharide constituted of one to four fructose molecules linked to a sucrose molecule.
Aims of the invention The present invention aims to produce bulking agents which do not exhibit or which exhibit in a greatly abated way, the undesirable digestive disorders due to the conventional bulking agents.
Another aim of the present invention is to supply a bulking agent which exhibits the same advantageous properties as the linear fructo-oligosaccharides, such as neutral and sweet tastes, absence of smell, low calorific value, dietary fiber effect, bifidogenic effect and natural and nontoxic character of the product.
Another aim of the present invention consists in producing products which are more soluble.
Another aim of the present invention consists in supplying products which can be used in a conventional way, using the standard processes for preparing sugars and syrups.
Other camplementaxy airs of the present. invention ie in -the use of the product of the invention as a sweetener, as a low-calorie or weakly cariogenic food, as a bifidogenic product or a produces with a REPhACEMENT SHEET
fiber effect, as a means of lowering the cholesterol level or of improving the condition of the intestinal flora, etc.
Other aims and advantages will become apparent in the description which follows.
Description of the invention The present invention relates to branched fructo-oligosaccharides consisting of a main chain and of one or more side chains, characterized in that the main chain and the side chains) consist mainly of fructose units, the main chain contains from 2 to 15 units and at least one branching point on one fructose unit, the branching of said at least one branching point consisting of a fructose-fructose bond, with the exception of the natural products.
The present invention also relates to a c~sition consisting-of one or mare branched fructoroLigosaccharides according to the invention and, more particularly, to mixtures consisting, in addition to the branched fructo--oLigosarchar~.de ( s ) , of other ingredients such as Pr~~~ ~-i-Pig or fatty acids, carbohydrates, fibers and other additives. -In particular, these ingredients may be products taken frcsn the following nonlimiting list: sweeteners such as saccharose, products of the hydrolysis of the starch, palatinose, sucrose, glucose, fructose, glucose syrups or polyalcohols derived fran sugar such as sorbitol, xyLitol, erythritol, mannitol, maltitol, lactitol or :isan~lt~ leucritol;
bulking agents such as polydextrose, cellulose, hemicellulose or fructoroligosaccharides; or, again, s~a~eeteners with a high sweetening power such as aspartame, acesulfame, saccharin, stevioside, sucralose and other dipeptide sweeteners, etc.
The products according to the invention are particularly suitable for use in human or animal feeding as bulking agents, as sweeteners, as low-calorie or weakly cariogenic foods, as bifidogenic prod~u~cts or products which improve the intestinal flora, as products with a dietary fiber effect, as agents for reducing the cholesterol 3 0 l~- ~. again, to improve the tolerance of food products. Zhe present invention relates also to a pharmaceutical cat~osition comprising a branched fzvcto-oligosar_chari~de accor<lir~g to the invention and possibly a suitable carrier.
Finally, the present invention also relates to processes for preparing these branched fructoroLigosaccharides.
-7a-In nar+;cular, the products according to the invention can be obtained by synthesis from sugar or fran mixtures of fructose, optionally through the intexmedi.acy catalysts or enzymes or by interaction of various enzymes with the sucrose of the fructo-oLigosaccharides, inulin or fructans or chemically, that is to say by polymerization, principally of fructose, or by extraction frcm vegetable sources containing the said fructans, or, 2~~~61~~
again, by hydrolysis of branched fructose polymers.
The fruc-to-oligosaccharides according to the invention can, in particular, be obtained from sucrose, fructose syrups, fructose in the crystalline form, fructans, levans, inulin, their hydrolysis products or, finally, products extracted from plants containing fructans.
Through the intervention of various enzymes, such as for example fructosyltransferase, levansucrase, etc., it is also possible selectively to form bonds which make it possible to implant fructose units at specified positions on other fructose units in the oligosaccharide chains. Enzymes may be used either consecutively or simultaneously. Preferably, enzymes will be used which preferentially form different bonds from those of the substrate.
For the production of branched fructo-oligo saccharides, optionally enzymatic processes of condensa tion or of synthesis, or, again, hydrolytic processes may be used.
By condensation of fructose monomers, it is possible to obtain an "at random" polymerization which may be followed by a chromatographic separation.
It is also possible to obtain branched fructo oligosaccharides by hydrolysis of synthesized branched molecules or of those which exist in the natural state.
In this case, it is also possible to use several different hydrolysis techniques, especially the technique of acid hydrolysis, the technique of alkaline hydrolysis or the technique of enzymatic hydrolysis.
In particular, specific enzymatic hydrolysis such as, for example, the interaction of endoinulase with the mixture of branched fructans isolated from Cordyline australis ("cabbage tree"), which specifically attacks the (i(2~1) bonds, gives rise to branched fructo-oligo-saccharides.
The result depends on the nature of the starting material and on the hydrolysis technique used and, optionally, the enzymes used for the hydrolysis process Y C
and the reaction conditions. According to the reaction conditions, new branching points may be produced during the hydrolysis reaction of branched or linear molecules.
Reducing end groups can, in addition, be chemi tally converted, for example by oxidation, by reduction or by hydrogenation, etc.
The present invention also relates to a process which makes it possible to render the ir~ulin more soluble by a very incomplete hydrolysis, followed by a branching reaction.
The processes used and the products obtained are better described with the help of the examples which follow.
Example 1: Preparation of branched fructan polymers by hydrolysis A mixture of branched fructans can be obtained from the "cabbage tree" (Cordyline australis) by extrac-ting with methanol, washing with water followed by precipitation in an acetone/ethanol solution and drying.
The substances obtained consist principally of glucose and fructose units in a ratio of 1 to 16, arranged in chains with an average degree of polymeriza-tion equal to 18, where approximately 15$ of the fructose units have a branching point.
A 25° Brix solution is heated to 90°C and then 2N HC1 is rapidly added until a pH of 2.5 is obtained.
After reacting for 2 minutes, the hydrolysis is stopped by adding NaOH (3M) until a pH of 6.5 is obtained.
This solution is then filtered and demineralized by a double treatment on cationic and anionic ion exchangers. The glucose, the fructose and the sucrose formed by hydrolysis are then removed by chromatographic separation on a cationic column in the potassium form.
The mixture of oligosaccharides thus obtained contains between 5 and 10~ of mono- and disaccharides and from 90 to 95~ of oligosaccharides. The average degree of poly-merization of the composition thus obtained is approxi-mately 5 and approximately 40~ of the molecules therein are branched.
ExAMPLE 2: Preparation of the product according to the invention by synthesis In this case, the enzyme levansucrase, derived from Bacillus subtilis, is used.
It has been observed that 'this enzyme, when incu-bated under suitable conditions in the presence of sucrose and of fructo-oligosaccharides of the p(2-~1) type, forms branched fructo-oligosaccharides.
In this example, the base fructo-oligosaccharides used are obtained by enzymatic hydrolysis of inulin by endo-inulinase obtained from the enzymatic preparation Novozyme 230.
A 40° Brix solution consisting of 50~ sucrose and 50$ base fructo-oligosaccharides is prepared in a 0.05M
phosphate buffer solution at a pH of 6.
A solution of levansucrase which contains 20 U/ml - 1 U being the quantity of enzyme necessary to release 1 micromole of glucose per minute - is added to the mixture in such a way as to obtain 4 U of levansucrase per gram of dry carbohydrate matter in the mixture. The solution is then incubated at 30°C for 18 hours in an orbital shaker (150 rev/min). The enzymatic reaction is then halted by cooking the reaction mixture for 5 minutes. Linear, long chain p-fructans (DP>12) are separated off by precipitating with 80~ ethanol.
After centrifuging (30 minutes at 5000 rev/min) and evaporating off the ethanol under vacuum, the solu-tion is demineralized on ion exchangers such as described in Example 1.
Th2 mixture obtained is then subjected to a chromatographic analysis. The chromatogram is represented in Figure 1.
The reaction mixture contains at this point approximately 27$ glucose, 3~ fructose, 3~ sucrose and 67~ fructans with a DP>2, of which approximately 60~ has a DP<12 and 40~ has a DPzl2. This fraction with a DPzl2 cannot be precipitated with 80~ ethanol, which is an indication of its branched nature. Approximately 40~ of the molecules which have a DP of 3 to 12 are branched 2~'~~~~~~f {cf. chroma.togram Figure 1).
The monosaccharides are principally removed by chromatographic separation.
The final product thus obtained contains approxi matel.y 90 to 95% of oligosaccharides with an average degree of polymerization equal to 4.5-5 and where X10 to 50% of the molecules are branched.
The branched fructo-oligosaccharides exhibit unexpected tolerance properties while still retaining the other advantageous properties of linear fructo oligosaccharides: neutral and sweet taste, absence of smell, low calorific value, dietary fiber effect, bi.fido-genic effect and natural and nontoxic character.
The branched fructo-oligosaccharides can also be used as sugar substitutes in all the standard and indus trial applications described for linear frucao-oligosacc harides.
The improved tolerance of these branched fructo--oligoposaccharides was demonstrated by carrying out the following in-vitro and in-vivo tests:
1. IN-VITRO Tests Fresh fecal materials from male subjects in good health were homogenized with 5 times their caeight of isotonic NaKCl in an anaerobic environment. Five 10 ml aliquot fractions of this homogenized mixture were used per test group.
As reference test group, 5 incubations were carried out in test tubes containing 20 g~l of a mixture of fructo-oligosaccharides consisting of 5% of glucose, fructose and sucrose, 35% of GF2, 50% of GF3 and 10% of GF4 (G = glucose, F = fructose).
As second test group, 5 incubations were carried out in test tubes containing 20 ml/1 of the mixture of branched fructo-oligosaccharides described in Example 1.
The test tubes are sealed with a sheet of paraf-fin wax whose displacement indicates the production of gas.
The formation of gas was monitored for 12 hours.
It is expressed in centimeters of displacement per hour.
R~P~AC~ra~rrx sH~ET
~~~o~~'l These tests show that the formation of gas per hour in the case of branched fructo-oligosaccharides reaches only 35~ of that dine to linear fructo-oligosaccharides.
2. IN-VIVO Tests During an experiment carried out on three male subjects sensitive to fermentation in the large rotes-.
tine, various quantities of fructo-oligosaccharides were mixed in fruit juices taken at breakfast, this breakfast usually consisting o.f fruit juice, bread and coffee in the usual quantities. The dose introduced is gradually increased in 10 g doses from an initial dose also of 10 g. Between two test breakfasts, at least two days elapse without any test.
The reactions of the subjects were recorded for each concewtration and more specifically as regards the following criteria: flatulence, gastric noises, intes-tinal cramps, soft stools and diarrhea. The "stopping dose" is defined as the first dose where one or more of these side effects are felt to be uncomfortable.
The substances tested which were introduced into the fruit juice are the following:
substance A: mixture of linear fructo-oligosaccharides such as described above in the prior art;
substance B: mixture of branched fructo-oligosaccharides such as described in Example 2.
Substance C: mixture containing 505 of substance A and 50~ of substance B.
The results obtained are dP~r~r;hA~a ;" ,-,", following table:
STOPPING DOSE A B C
VOLUNTEER 1 20 g 40 g 30 g VOLUNTEER 2 30 g 60 g 50 g VOLUNTEER 3 40 g 60 g 50 g From this table, it can be concluded that the branched fructo-oligosaccharides are tolerated better than the linear oligosaccharides and that by introducing a certain quantity of branched fructo-oligosaccharides into a mixture which also comprises linear fructo-oligosaccha.rides, the tolerance of this mixture is increased.
Properties Low-calorie product The branched fructo-oligosaccharides are not hydrolyzed by human digestive enzymes. These substances thus have a low calorie contribution.
Weakly cariog_enic product The branched fructo-oligosaccharides are less cariogenic than sucrose. This is explained by the fact that they are not used as substrate for the formation of dental plaque and that they are less capable of causing the formation of acid by the oral flora.
Products with bifidoQenic activity and which improve the intestinal flora The branched fructo-oligosaccharides have a selective bifidogenic effect: they stimulate in a speci-fic way the growth of the bifid population in the large intestine. This is explained by the fact that these fructo-oligosaccharides are used as an energy source by the bacteria belonging to the Bifidobacteria group, whereas other bacteria are much less able to use this substrate. In particular, a certain number of putref-active bacteria (such as Salmonella and Clostridium) have their growth limited, which brings about a qualitative and quantitative improvement in the intestinal flora.
Product with dietary fiber effect and which reduces the cholesterol level The fructo-oligosaccharides have a dietary fiber effect: they reduce the intestinal transit time and increase the fecal mass. This is explained by the fact that these fructo-oligosaccharides are not absorbed in the small intestine and pass into the large intestine where they undergo a fermentation. These fructo-oligo-saccharides also cause a reduction in the blood chole-sterol level as a result of their dietary fiber effect.
Diuretic agent The branched frueto-oligosaccharides can be used for the 2~~~~~ ~~
prevent ion or the treatment of al.l those disorders which may be caused by the presence of products such as, for example, accumulated degradation products which can be the cause of kidney disorders, liver disorders or of cancer, etc.
Product which improves the tolerance of other products It is already known that branched fructo-oligo-saccharides are tolerated better than their linear analogs.
Indeed, the branched molecules constitute fermen-tation substrates which are more difficult for the intestinal flora; the fermentation is thus retarded by the presence of these molecules.
It is thus possible to improve the tolerance of fermentable foods by adding branched fructo-oligo saccharies to the diet, due to the reduction and slowing down of the fermentation phenomena.
Solubility of the product The branched fructo-oligosaccharides have a higher solubility than that of the linear compounds, which allows them to be used more readily in a certain number of products (cold sparkling or dairy drinks, other dairy products, confectionery, biscuits, etc.j where high concentrations of sugars must be used.
The combination of these last two properties, namely the increased tolerance of the branched fructo-oligosaccharides and the increased solubility of the product according to the invention favor their use as bulking agents.
Increased stability in acids medium The branched fructo-oligosaccharides have better stability in acidic medium than the linear compounds, and this makes it possible to limit their degradation ( forma-tion of saccharides such as fructose, glucose and sucrose) during the manufacture and the storage of acidic foods and to guarantee that the latter have characteris-tics which are more constant during their lifetime.
The increase in the stability in acidic medium was revealed during a comparative experiment carried out with two substances:
Substance A: mixture of linear fructo-oligosaccharides containing 5~ of glucose, fructose and sucrose 35~ of GF2 50~ of GF3 10~ of GF4 Substance B: mixture of branched fructo-oligo-saccharides as described in Example 1~
Each of 'the substances A and B was taken up in 10 ° Brix aqueous solution; the pH was then ad justed to 3.5 with the aid of hydrochloric acid.
The solutions thus obtained were stored for several weeks at 20°C. The stability of the fructo oligosaccharides in these solutions was followed by the development of glucose and sucrose contents {determined by gas chromatography) during storage.
The results obtained are described in the table below:
Table: Fructose, glucose and sucrose content in ~
Storage time Substance at 20 A B
C and pH = 3.5 4 weeks 18 11 8 weeks ~ 32 21 Applications The branched fructo-oligosaccharides can be incorporated into foods or prepared in the form of granules or tablets. In the latter case, they can be used as oral pharmaceutical compositions, for example to selectively stimulate the growth of the bifid population, as a diuretic, etc.
The frudto-oligosaccharides have properties comparable to those of sugar and glucose syrups; they can therefore be used in the same way. They can replace sugar and glucose syrups in the majority of applications, . CA 02076647 2000-03-30 especially in the following products:
- confectionery (sweets, etc.), - jelly products (gums, etc.), - chocolate-based preparations, - chewing gum, biscuits, .
- ice creams and sorbets, -- dairy products, ' - fruit-based drinks, - fruit jams and preparations, caramels, - phanaaceutical preparations, etc.
The branched fructo-oligosaccharides have, in particular, suitable properties for replacing sugar and glucose syrups in the preparation of low calorie, weakly cariogenic, bifidogenic and/or diet products.
The present invention ~is illustrated by a non-limiting range of examples of possible applications.
As base product, a syrup of branched fructo oligosaccharides, prepared as described in Example 1 or Example 2, was used.
The products according to the invention were evaluated by a panel of about twenty tasters in order to compare their properties with those of conventional products based on sucrose and/or glucose syrup. These tests revealed a high acceptance of products based on branched fructo-oligosaccharides.
EXAMPLE 3: Preparation of a milk ice cream Ingredients (by weight):
Skimmed milk powder 13.00 Water 62.46 Cream (35% fatty matter) 8.60 Branched fructo-oligosaccharides of 15.00 Example 1 Stabilizer (Cremodan SE30~ Grindsted 0.50 Products ) Vanilla flavoring agent (Silesia 0.40 111/8309280)~
Aspartame (NutraSweet)~ 0.04 ~
Composition:
Total solids 28.5%
Milk solids 16.0%
Milk fats 3.0%
Preparation:
The various ingredients in powder form are mixed While dry and dissolved in water.
The branched fructo-oligosaccharides, the flavor ing agent and the cream are then added. The whole is mixed until a homogeneous product is obtained.
The mi::cture is heated to 80'C and this tempera-ture is maintained for 30 seconds . The mixture is then homogenized while hot (mixer) , cooled to 5'C
and lE:ft to stand for a few hours in the refrigerator. It is aerated (100%) and frozen in an ice cream making machine (Carpigiani)~
It is stored in a deep freeze.
~XAMpLE 4: Preparation of a sorbet Incredients (by weight):
' Strawberry purEe (6.5% solids) 74.48 Branched fructo-oligosaccharides of 25.00 Examples 1 Stabil:Lzer (Fructodan SL64~ Grinsted 0.45 Products) Aspartame (NutraSweet) 0.07 Composition: 2:i% solids.
reparation:
The ingredients are thoroughly mixed, heated to 80'C and held at this temperature for 30 seconds.
The mixture is then cooled to 5'C and kept in the refrigerator for a few hours . It is aerated ( 75% ) and frozen in an ice cream making machine ( Carpigiani ) It is stored in a deep freeze .
EXAI~LE 5: Preparation of a iam Ingredients (by weight):
Strawberries (10% solids) 65.00 Branched fructo-oligosaccharides of 42.00 Example 1 ~
..
~ , WO 91/13076 - 18 - PCT/BE91/00014 Water 25.00 Pectin (LM 27NH95~ Sanofi Bio-Industrie) 1.00 Citric: acid ( 50% ) 0 . 80 Comvosition: 40% solids.
~regaration:
The pectin is dissolved in warm water ( 60'C) , and it is then thoroughly mixed with the straw berriea. The mixture is left to cook, with thorough stirring, until a product with a weight of 57 g is obtained.
The branched fructo-oligosaccharides, heated to 60'C, are then added. The citric acid is then added.. The mixture is allowed to cool to 75'C and is packed into glass jars.
EXAMPLE 6: Pre~earation of a yo hurt Ingredients (by weight) Whole milk (3.7% fatty~matter) 94.10 Skimms:d milk powder ~ 1.90 Yoghurt fermenting agents 1.00 Branched fructo-oligosaccharides of 3.00 Example 1 Composition:
Total solids 16.0%
Milk solids 13.5%
25~ Milk fats 3.5%
preparation:
The milk powder and the branched fructo-oligo-saccharides are mixed with the cold milk. The mixture is then heated to 6 0' C and homogenized .
3CI It is. then heated to 90'C and held at this temperature for 10 minutes.
The mixture is cooled to 45'C and is seeded with lactic fermenting agents. The mixture is trans ferred into preheated pots and incubated at 43'C
3:i to a ;pH o f 4 . 2 .
The product is stored at 10'C maximum.
~ WO 9I/13076 - 19 - PCT/BE91/00014 EXAMPLE 7: Preparation of a fruit cake Ingredients (by weight) Branched fructo-oligosaccharides of 25.30 Example 1 Margarine 8.50 Whole eggs 10.10 Ammonium carbonate/bicarbonate 0.40 Flour ~ 33.65 Milk 6.80 Raisins 10.10 Dried fruit 5.10 Acesulfame R ~ 0.05 Preparation:
Mix the branched fructo-oligosaccharides with the margarine, add the eggs, and the ammonium car bonate, the Acesulfame K and the bicarbonate dissolved in 0.5 liter of milk. Add the flour and the teat of the milk. Mix until a homogeneous mixture is obtained . Then add the rais ins and the dried fruit. Transfer the whole into a mold and bake in an oven at 250'C.
EXAMPLE 8: Preparation of a sponge cake Ingredients (by weight):
Branched fructo-oligosaccharides of 27.00 Example 1 Eggs 49.80 Flour 27.00 Butte=' 8.30 Acesul,fame K~(Fioechst) 0.05 Preparation:
Beat the branched fructo-oligosaccharides and the whole eggs in a bain-marie until a thick foam is obtained which has a density of t0.?5.
Sift the flour and add it to the paste while mixing~~ gently. Heat the butter until it is half melted and mix it with the dough. Pour the dough into a pregreased mold and cook in the oven for 20 minutes at 175'.
ERAI~LE 9: Preparation of cams Ingredients (by weight):
Branched fructo-oligosaccharides of 94.00 Example 2 Gelatin 200 BLS ~(Sanofi Bio-Industrie) 6.50 Water 13.50_ 50% citric acid solution 1.50-Cola LE 1613 ~(Sanofi Bio-Industrie) 0.10 Aspartame 0.26 Solids content of the finished product: 80%.
Preparation:
The gelatin is dissolved in hot water (80' to 90'C). The branched fructo-oligosaccharides are cooked at 115'C. The syrup is then cooled to 100'C. The gelatin solution is then added to this syrup. The air bubbles are removed from this syrup by bringing it under vacuum or by leaving it to stand.. The mass is cooled to approximately 80°C. The flavoring agent, the colorant, Aspartame and citric acid are added and the mixture is poured into starch molds. The starch is used at a temperature of approximately 30'-35'C. The gums ate covered with a starch . layer and are left to stand for 24 hours at room temperature. The powder is then removed from the gums and the latter are coated with oil.
~,XAMPLE 10: preparation of hard cams ~nqredients (by weight):
Branched fructo-oligosaccharides of 96.50 . Example 2 Gelatin GAT 15 ~ 11.00 Water 16.50 50% citric acid solution 1.50 Mandarin flavoring agent LE 1450~(Sanofi 0.25 Bio-Industries) Aspartame,~ . ~ 0.28 Solids content of the finished product: 88%.
~revaration:
The gelatin is dissolved in hot water (80'-90'C) .
~ WO 91/13076 - 21 - PCT/BE9I/00014 The branched fructo-oligosaccharides are cooked at 113''C. The syrup is then cooled to 100'C. The gelatin solution is then added to this syrup. The air bubbles are removed from this syrup and the mass is cooled to approximately 80'C. The flavor-ing agent, the colorant, Aspartame and citric_ acid are added. The mixture is poured into starch .
molds. The starch is used at a temperature of approximately 30'-35'C.
The gums are covered with a starch layer.
They a:re left to stand in a ventilated oven for ? 2 hours at 5 0' C . The powder is then removed from the gums and the latter are coated with oil.
EX,AI~LE 11: preparation of hard sweets Ingredients (by weight):
Branched fructo-aligosaccharides of 125.00 Example 1 Citric acid (100%) 0.83 Extract HE4017~(Sanofi Bio-Industrie) 0.10 Lemon :Flavoring agent LE 1616~(Sanofi~ 0.15 Bio-Industrie) Acesul:fame K ~ 0 . 34 Solids content of the finished product: 98%.
,Preparation: , The branched fructo-oligosaccharides are heated at a temperature of 165'C until a solids content of 98% is obtained.
. The syrup is cooled to a temperature of t110'C;
the colorant, the flavoring agent, Acesulfame R
and citric acid are then mixed with the product obtained. The product obtained is then poured into molds . After cooling, the sweets are removed from the molds.
EXAI~LE 12: Preparation of caramels ~nqredients (by weight) Branched fructo-oligosaccharides of 68.60 Example 1 Sweetened condensed milk 26.00 Fat melting at 32'C 5.20 ' WO 91/13076 - 22 - PCT/BE91/00014 Salt 0.20 Lecithin 0.20 Acesul:Eame R. ~ 0 .24 Preparation:
Dissolve the lecithin in the fat in a bain-marie at 70'C.
Pour the branched fructo-oligosaccharides, the~-sweetened condensed milk, the salt, Acesulfame R
and the mixture consisting of fat and lecithin into a cooking pot. Mix and heat the mixture to 55-60'C.
Raise the temperature to 119-121'C. Then pour onto a cooling tray and allow to cool to 35-40'C.
EXA1~LE 13: Preparation of a_puddinq Ineredients (by weight):
Skimmed milk 84.94 Skimmed milk powder 1.80 - Branche:d fructo-oligosaccharides of 10.00 ExamplE: 1 Aspart~une (NutraSweet)~ 0.03 Starch (Snowflake 06304~ Cerestar) 3.00 Carrageenan (Genulacta SGI-1 ~ Hercules) 0.20 vanilla flavoring agent (Flav-o-lok 0.02 630019H ~ PFW Products) Cream-yellow colorant (51798,.Ned. 0.01 Kleurstofindustrie) Comt~ositions 20% solids .
Preparation:
The ingredients in powder form are mixed while dry; the cold milk is then added. The ingredients are then mixed until a homogeneous mixture is obtained.
The mixture .is heated to 95'C and is held at this temperature for 5 minutes.
The whole is cooled to 50'C while stirring the mixture. The mixture is packed into dishes and stored in the refrigerator.
~X,AI~LE 14: Preparation of a fruit-based drink Ingredients (by Weight):
Concentrated fruit juice (Orange PG31332 ~ 3.80 Quest Int.) Branched fructo-oligosaccharides of 7.00 Example 1 Sucrose 7.50 Citric acid (50%) 0.30 Water 81.40 Composition:
Solids 14.5%
Fruit juice 15.0%
Freoaration:
Dissolve the sugar in the water . Add the other ingredients and mix thoroughly. Store in the refrigerator.
Examgle 15: Enzymatic treatment of inulin A 40 Brix solution, consisting of 50% sucrose and 50% inu.lin, which contains a large proportion of molecules with a high degree of polymerization (DP), 3.s adjusted to a pH of 5.4. This solution is divided into two fractions.
A solution of levansucrase (LS) is added to the first ;fraction so as to obtain 2 U of levan sucrase per gram of solid while bringing the pH
to 5. The solution is then incubated at 37'C for 18 hours. The enzymatic reaction is then halted by cooking the reaction mixture for five minutes .
0.6 U o~f endoinulase, obtained from the enzymatic preparation of Novozyme 230, per gram of solid is added i:o the second fraction. The incubation is halted after one hour by cooking the reaction mixture: for five minutes. A solution of levansucrase is then added as described above.
The percentage of precipitation in an 80% ethanol solution is determined for the various fractions 2~~~~~j.~'~
~ of precipitate calculated for all the products with DP > 2 Base solution 66 Base solution + LS 40 Base solution + endoinul. 15 Base solution -f endoinul. + LS 2.5 This shows that the action of l.evansucrase has a significant effect on the solubility of linear carbo-hydrates of the inulin type. It is evident that other linear chains, e.g. based on 2>6 (phlein type) bonds can also be branched by using a suitable enzyme, which preferentially forms other bonds than those of the linear chain such as, for example, of the 2-~l type (fructosyl transferase). This technique could even be applied to glucoside chains.
By starting from an inulin with a mean DP
markedly lower than that used in the example, e.g. by starting from the inulin of Jerusalem artichoke, levan sucrase can be made to act directly on the inul.i.n without prior hydrolysis.
In tabular form, the gas phase chromatographic analysis of the various fractions. As can be seen from this table, an increase is recorded in the proportion of products with DP 5, DP 6, DP 7, DP 8, DP 9 and DP 10 and of soluble products which it was not possible to separate by means of the column used (DP 10+). In addition, it is possible to see on the chromatogram that the shape of certain peaks of the reaction product is different from the peaks of the starting material (the presence of a shoulder, showing the presence of two products) and that, in addition, other products have been formed which can no longer be found in the chromatogram of the levan. This clearly shows that levansucrase has transferred fructose molecules from the sucrose to the linear chain.
Glucose is then removed from the fraction which was treated with endoinulase and levansucrase by fermen-tation. The product thus obtained is permethylated by following the slightly modified method described in the paper by Goran Larson et al.: ~~Application of a simple REPLACEMENT SHEET
rnethylation procedure for the analysis of glycosphingo-lipids", published in Carbohydrate Research, Vol. 161, p.
2$1-290 (1987).
After the permethylation,, the hydrolysis which makes it possible to produce monosaccharides and the silylation of 'the monosaccharides, the latter are sepa rated into dimethyl-, trimethyl- and tetramethylfructoses by gas phase chromatography. The presence of dimethyl fructose in the chromatogram is proof of the presence in the saccharide chains of fructose molecules bonded to three other molecules. In addition, it is possible to detect isomers of trimethylfructose such as 3,4,6- and 1,3,4-trimethylfructose which indicates the presence in the molecules of 1-»2 and 2-~6 bonds. This clearly proves that the action of levansucrase on the linear chain of the inulin gives rise to branching points both of the type:
Frul 2Fru1 2Fru 2Fru and of the type:
Frul 2Fru6 2Fru Table I which follows shows the result of the gas phase chromatographic analysis of the various fractions of the products of Example 15.
I
TABLE I
INULIN+SUCROSE A+I~SA+ENDO lhr B+LS
{50/50) {A) (B) Fructose 1.3 4.8 1.4 3.6 Glucose 0.45 28 0.5 26.4 Sucrose 49.7 9.5 51.4 4.6 DFA 0.2 0.3 0.3 0.2 F2 0.4 0.2 0.4 0.3 GF2 1.3 0.6 1.3 0.8 F3 1.6 0.01 6.5 2 GF3 1.8 0.7 2 1 F4 1.0 0.1 5.5 4.5 GF4 2 0.9 4.3 1.6 F5 0.4 2.4 3 4,9 GF5 1.8 0.9 3.7 2.5 F6 0.3 0.2 2 3.2 GF6 1.4 1 3 2.9 F7 0.1 0.1 1.:.~ 2.7 GF7 1.2 1.1 1.2 3 F8 0.1 0.2 0.3 2.3 GF8 1 1.3 0.6 2.8 F9 0.05 0.1 0.2 DP10 0.2 1.1 0 1.8 DP10+ 0 22 3.8 27 Precipitate 33 23.5 7.1 1.7 (DFA = Di-Fructose Anhydride) ItEPLAGEMEP1T SHEET
Claims (31)
1. Branched fructo-oligosaccharide consisting of a main chain and of one or more side chains, characterized in that the main chain and the side chain(s) consist mainly of fructose units, the main chain contains from 2 to 15 units and at least one branching point on one fructose unit, the branching at said at least one branching point consisting of a fructose-fructose bond, with the exception of the natural products: kestose, O-.beta.-D-fructofuranosyl-(2~1)-O-[O-.beta.-D-fructofuranosyl-(2~6)]-.beta.-D-fructofuranosyl-.alpha.-D-glucopyranoside, O-.beta.-D-fructofuranosyl-(2~1)-.beta.-D-fructofuranosyl-(2~1)-O-[O-.beta.-D-fructofuranosyl-(2~6)]-.beta.-D-fructofuranosyl-.alpha.-D-glucopyranoside and products having the following structure:
a) X = Glu1 n = 2 ~Y = 2Fru b) X = Glu1 n = 3 Y = 2Fru6-2Fru c) X = Fru1 n = 3 ~Y = 2Fru6-2Fru d) X = Glu1 n = 3 ~Y = 2Fru e) X = Glu1-2Fru6 n = 2 f) X = Glu1 n = 1 ~Y = -(2Fru6)-m; m = 1 to 12
a) X = Glu1 n = 2 ~Y = 2Fru b) X = Glu1 n = 3 Y = 2Fru6-2Fru c) X = Fru1 n = 3 ~Y = 2Fru6-2Fru d) X = Glu1 n = 3 ~Y = 2Fru e) X = Glu1-2Fru6 n = 2 f) X = Glu1 n = 1 ~Y = -(2Fru6)-m; m = 1 to 12
2. Branched fructo-oligosaccharide according to claim 1, characterized in that the main chain consists of fructose units.
3.. Branched fructo-oligosaccharide according to claim 1 or 2, characterized in that the side chain(s) consist(s) of 1 to 15 units.
9:. Branched fructo-oligosaccharide according to any one of the claims 1 to 3, characterized in that the side chain(s) consist(s) of fructose units.
5. Branched fructo-oligosaccharide according to any one of the claims 1 to 4, characterized in that the side chain(s) is/are unbranched.
6. Branched fructo-oligosaccharide according to any one of the claims 1 to 4, characterized in that one or more side chains are, in their turn, branched into additional side chairs.
7. Process for the preparation of branched fructo-oligosaccharides according to any one of the claims 1 to 6, characterized in that the said fructo-oligosaccharides are obtained by extraction and partial hydrolysis of branched fructans, or from vegetable sources containing the said fructans.
8. Process for the preparation of branched fructo-oligosaccharides according to any one of the claims 1 to 6, characterized in that the said fructo-oligosaccharides are obtained by enzymatic synthesis, which synthesis involves reaction of saccharides containing fructose of which said fructose acts on at least one fructo-oligosaccharide, used as substrate, by using an enzyme which forms fructose-fructose bonds other than those which exist in the fructo-oligosaccharide used as a substrate.
9. Process according to clam 8, characterized in that a fructosyltransferase is used which forms bonds other than those present in the main chain of the fructo-oligosaccharide used as substrate.
10. Process for the preparation of branched fructo-oligosaccharides according to any one of the claims 1 to 6, characterized in that the said branched fructo-oligosaccharides are obtained by enzymatic synthesis from saccharides containing fructose by using, simultaneously or not, several enzymes which form different bonds.
11. Process for the preparation of branched fructo-oligosaccharides, characterized in that the said fructo-oligosaccharides are obtained by a combination of the processes of claims 7 to 10.
12. Process for improving the solubility of linear fructans, characterized in that a branching reaction is carried out by means of a process according to any one of claims 8 to 11.
13. Process for improving the solubility of linear fructans according to claim 12, the linear fructan being inulin.
14. Composition, characterized in that it consists of one or more branched fructo-oligosaccharides according to any one of claim 1 to 6, and other ingredients, consisting of at least one selected from the group consisting of proteins, lipids, fatty acids, carbohydrates, dietary fibres, bulking agents and additives.
15. Composition according to claim 14, wherein the bulking agents are selected from the group consisting of polydextrose, cellulose, and hemicellulose, fructo-oligosaccharides and other oligosaccharides.
16. Composition according to claim 15, wherein the additives are from the following list consisting of sweeteners, sugar alcohols, fructo-oligosaccharides, other oligosaccharides and sweeteners with a high sweetening power.
17. Composition according to claim 16 wherein the sweeteners are from the following list consisting of sucrose, glucose, fructose, hydrolysis products of starch, palatinose;
the sugar alcohols are from the following list consisting of sorbitol, xylitol, erythritol, mannitol, maltitol, lactitol, isomalt and leucritol; and sweeteners with a high sweetening power are selected from the group consisting of aspartame R, acesultame R, saccharin R, stevia R, and sucralose R.
the sugar alcohols are from the following list consisting of sorbitol, xylitol, erythritol, mannitol, maltitol, lactitol, isomalt and leucritol; and sweeteners with a high sweetening power are selected from the group consisting of aspartame R, acesultame R, saccharin R, stevia R, and sucralose R.
18. Composition according to claim 16 wherein the sweeteners with a high sweetening power are dipeptides.
19. Food for human beings or animals, characterized in that it comprises one or more fructo-oligosaccharides according to any one of claims 1 to 6 or a composition according to any one of claims 14 to 18.
20. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as a bulking agent,
21. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as a sweetener.
22. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as a low-calorie food.
23. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as a food which is less cariogenic than the corresponding food product using saccharose.
24. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as a bifidogenic agent.
25. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as an agent having a limiting effect on the growth of putrefactive bacteria.
26. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as an agent having a cholesterol level reducing effect.
27. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as an agent with a dietary fiber effect.
28. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as an agent having a diuretic effect.
29. Pharmaceutical composition, characterized in that it comprises a branched fructo-oligosaccharide according to any one of the preceding claims 1 to 6 or a composition according to any one of claims 14 to 18, and a pharmaceutically acceptable carrier.
30. Pharmaceutical composition according to claim 29, characterized in that it additionally comprises a filler.
31. Process according to claim 12, wherein as a substrate is used a linear fructan or a linear fructan which, having regard to its degree of polymerization, has been subjected to partial hydrolysis.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9000213 | 1990-02-23 | ||
BE9000213A BE1003826A3 (en) | 1990-02-23 | 1990-02-23 | Fructo-oligosaccharides branched, method for their production and use of products containing. |
PCT/BE1991/000014 WO1991013076A1 (en) | 1990-02-23 | 1991-02-22 | Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2076647A1 CA2076647A1 (en) | 1991-08-24 |
CA2076647C true CA2076647C (en) | 2001-10-02 |
Family
ID=3884689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002076647A Expired - Lifetime CA2076647C (en) | 1990-02-23 | 1991-02-22 | Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0515456B1 (en) |
JP (1) | JP3066070B2 (en) |
AU (1) | AU7235491A (en) |
BE (1) | BE1003826A3 (en) |
CA (1) | CA2076647C (en) |
DE (1) | DE69101914T2 (en) |
ES (1) | ES2053322T3 (en) |
WO (1) | WO1991013076A1 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2061498A1 (en) * | 1991-02-26 | 1992-08-27 | Andrew C. Hoefler | Fat substitute |
BE1005438A4 (en) * | 1991-10-04 | 1993-07-27 | Raffinerie Tirlemontoise Sa | Cream compositions containing fructan, their method of preparation and use compositions. |
FR2678166B1 (en) | 1991-06-27 | 1993-10-22 | Bioeurope | COSMETIC COMPOSITIONS CONTAINING GLUCOOLIGOSACCHARIDES. |
WO1992008368A1 (en) * | 1991-09-30 | 1992-05-29 | Wm. Wrigley Jr. Company | Chewing gum containing fructooligosaccharides |
DE4223051C2 (en) * | 1992-07-14 | 1996-12-19 | Rolf Paul Prof Dr Claus | Use of dietary products to specifically inhibit the intestinal formation of 3-methyl indole in pigs |
BE1006377A3 (en) * | 1992-11-24 | 1994-08-09 | Raffinerie Tirlemontoise Sa | SEPARATION METHOD OF polydispersed composition SACCHARIDES, PRODUCTS OBTAINED BY THE METHOD AND USE OF PRODUCTS OBTAINED IN FOOD COMPOSITIONS. |
US6025542A (en) * | 1992-12-28 | 2000-02-15 | Stichting Scheikundig Onderzoek In Nederland | Method for obtaining transgenic plants showing a modified fructan pattern |
ATE142436T1 (en) * | 1993-01-13 | 1996-09-15 | Unilever Nv | FAT SUBSTITUTE |
US5641759A (en) * | 1993-05-26 | 1997-06-24 | Purdue Research Foundation | Animal husbandry methods and compositions therefor |
DE4320816C1 (en) * | 1993-06-23 | 1994-08-25 | Saric Krunoslav | Animal feed having drinkable or chewable consistency |
DE4341780A1 (en) * | 1993-12-08 | 1995-06-14 | Suedzucker Ag | Hydrogenated fructooligosaccharides |
JPH07322835A (en) * | 1994-05-31 | 1995-12-12 | Aohata Kk | Low calorie jams |
NL9401140A (en) * | 1994-07-08 | 1996-02-01 | Stichting Scheikundig Onderzoe | Production of oligosaccharides in transgenic plants |
NL1000064C1 (en) * | 1994-07-08 | 1996-01-08 | Stichting Scheikundig Onderzoe | Production of oligosaccharides in transgenic plants. |
US5431929A (en) * | 1994-07-28 | 1995-07-11 | Wm. Wrigley Jr. Company | Chewing gum products using oligofructose |
GB9512106D0 (en) * | 1995-06-14 | 1995-08-09 | Norsk Naeringsmiddelforskning | Animal feed |
DE69624805T3 (en) * | 1996-07-31 | 2007-01-04 | Raffinerie Tirlemontoise, S.A. | Fructan and / or polydextrose containing milk product powders; Process for their preparation and use thereof |
NL1005438C1 (en) * | 1997-03-05 | 1998-09-08 | Leuven K U Res & Dev | Sweetener and food composition comprising such a sweetener. |
NZ500718A (en) * | 1997-04-18 | 2001-12-21 | Mcneil Ppc Inc | Solid, low calorie, palatable fiber-containing sugar substitute comprising insulin and high intensity sweetener like sucralose |
EP1310173B2 (en) * | 1997-06-23 | 2014-12-31 | Société des Produits Nestlé S.A. | Composition for providing nutrition to diabetics |
US7147883B1 (en) | 1998-08-27 | 2006-12-12 | Silver Barnard S | Compositions containing at least one polyol and inulin characterized by reduced tendencies of the at least one polyol to induce acute diarrhea |
US7186431B1 (en) | 1998-08-27 | 2007-03-06 | Barnard Stewart Silver | Sweetening compositions and foodstuffs comprised thereof |
KR100993978B1 (en) | 2002-04-26 | 2010-11-11 | 니혼 텐사이 세이토 가부시키가이샤 | A composition for improving bowel movement |
DE10303900A1 (en) * | 2003-01-31 | 2004-08-12 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Synergistic cholesterol lowering composition, useful as medicament or food or feed additive, comprising dietary fiber component and ahypocholesterolemic agent, e.g. statin |
IL181431A0 (en) * | 2007-02-19 | 2007-07-04 | Micha Shemer | Fruit juice and puree with a lowered amount of available sugars |
WO2016027231A1 (en) * | 2014-08-18 | 2016-02-25 | Mofin S.R.L. | Method for preparing milk-derived products based on cream, ricotta and mixtures thereof intended for quick- freezing or freezing, products obtained with said method and uses thereof |
CN115028511A (en) * | 2022-07-09 | 2022-09-09 | 浙江华康药业股份有限公司 | Preparation method of sorbitol solution |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2629985B1 (en) * | 1988-04-14 | 1994-01-21 | Roussel Uclaf | APPLICATION AS LOW-CALORIC SUGAR PRODUCTS OF FRUCTOSYLATED OLIGOSACCHARIDES AND FOODS, DIETETIC PRODUCTS AND BEVERAGES CONTAINING THEM |
-
1990
- 1990-02-23 BE BE9000213A patent/BE1003826A3/en not_active IP Right Cessation
-
1991
- 1991-02-22 AU AU72354/91A patent/AU7235491A/en not_active Abandoned
- 1991-02-22 CA CA002076647A patent/CA2076647C/en not_active Expired - Lifetime
- 1991-02-22 JP JP3503938A patent/JP3066070B2/en not_active Expired - Lifetime
- 1991-02-22 DE DE69101914T patent/DE69101914T2/en not_active Expired - Lifetime
- 1991-02-22 EP EP91903932A patent/EP0515456B1/en not_active Expired - Lifetime
- 1991-02-22 WO PCT/BE1991/000014 patent/WO1991013076A1/en active IP Right Grant
- 1991-02-22 ES ES91903932T patent/ES2053322T3/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0515456A1 (en) | 1992-12-02 |
DE69101914T2 (en) | 1994-08-18 |
AU7235491A (en) | 1991-09-18 |
EP0515456B1 (en) | 1994-05-04 |
JP3066070B2 (en) | 2000-07-17 |
JPH05504568A (en) | 1993-07-15 |
ES2053322T3 (en) | 1994-07-16 |
CA2076647A1 (en) | 1991-08-24 |
DE69101914D1 (en) | 1994-06-09 |
WO1991013076A1 (en) | 1991-09-05 |
BE1003826A3 (en) | 1992-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2076647C (en) | Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them | |
US5659028A (en) | Branched fructo-oligosaccharides, method for obtaining them and use of products containing them | |
JP6656184B2 (en) | Fiber-containing carbohydrate composition | |
Murphy | Non-polyol low-digestible carbohydrates: food applications and functional benefits | |
KR101760827B1 (en) | Carbohydrate compositions | |
Moynihan | Update on the nomenclature of carbohydrates and their dental effects | |
JP3602989B2 (en) | Fat substitute food | |
AU2003245923B2 (en) | Galactosyl isomalt, method for production and use thereof | |
CA2292662A1 (en) | Dietetic one-to-one sugar substitute composition for table top, baking and cooking applications | |
BRPI0706959B1 (en) | process for preparing saccharide oligomers, carbohydrate composition and food product | |
BRPI0707914A2 (en) | functional sugar substitution | |
US11241022B2 (en) | Short texture caramel | |
JP2016510604A (en) | Fiber-containing carbohydrate composition | |
JP2018024619A (en) | Endurance improver | |
JP3102624B2 (en) | Buckwheat candy-containing food | |
JP2000515745A (en) | Method for preparing polydisperse saccharide composition and obtained polydisperse saccharide composition | |
JP4982716B2 (en) | Saccharide mixture, production method and use thereof | |
JPH02234651A (en) | Preparation of low cariogenetic food or drink | |
TW202444391A (en) | Composition for inhibiting precipitation of carbohydrates or sugar alcohols | |
JPS637760A (en) | Preparation of low-cariogenic food and drink | |
IL165448A (en) | Galactosyl isomalt compositions and methods for producing galactosyl isomalt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |